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1. Introduction 
Toxicology is a multidisciplinary field involving biology, chemistry and medicine 
which investigates the interaction of chemicals with living organisms [1]. As 
toxicological studies are performed on new drugs (medicines), pesticides and 
food additives, toxicology plays a key role in our daily life. From a toxicological 
point of view, almost all substances that we ingest may cause damage to our 
organism. If a substance is toxic or non-toxic largely depends on the ingested 
quantity and the time of exposure. For instance, certain medicines have 
beneficial effects at lower doses, while others have no visible effects. However, 
an increase of the dose and the exposure time to some of these substances 
may lead to a negative response of an organism. For instance, acetaminophen 
is a worldwide used analgesic and it is safe a low doses [2], however, an 
acetaminophen overdose causes acute liver failure [3]. The liver plays a crucial 
role in the natural (non-specific) defense against chemical injuries [4]. Liver 
injury has been linked to nearly 1000 drugs and is the single most frequent 
reason to withdraw previously approved medications from the market [5]. 
Pharmaceutical toxicology tries to identify the effectiveness, the pathways of 
actions, and the risk assessment of the active chemicals of the compounds of 
medicines [6].  
1.2. Drug toxicity studies 
During the development of new medicaments, pharmaceutical companies 
perform toxicity tests in order to determine the acute, subchronic and chronic 
toxicity of the compounds. First, acute toxicity tests are performed and the 
toxicity is a single or brief exposure. Meanwhile, subchronic and chronic toxicity 
tests determine the effects and side-effects of a substance after repeated 
administration ranging from 1 to 2 weeks up to 1 to 2 years respectively [7].  
In the pharmaceutical industry, laboratory animals are used for traditional 
toxicity tests in order to prevent possible damage in human organism, e.g. 
cancer, birth defects [8]. Moreover, the development of genetically modified 
animals which allow for the study of specific health disorders, as for instance 
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cancer, has led to an increase of the number of animals in research [9]. In the 
European Union (EU), there are two documents that regulate the use of animals 
in research; the Convention for the Protection of Vertebrate Animals used for 
Experimental and other Scientific Purposes (ETS 123) of the Council of Europe 
(1985) and the Directive for the Protection of Vertebrate Animals used for 
Experimental and other Scientific Purposes (86/609/EEC) (1986). Both 
directives control the use of vertebrate animals in experiments that can cause 
pain, suffering and stress, provide welfare for the animals, and regulate the 
necessary training of researchers and animal staff, the use of anesthesia and 
euthanasia, the generation of statistics on animal experimentation as well as the 
supply of animals. However, animal testing presents some major drawbacks, 
like e.g. high costs (accommodation and maintenance of animals), ethical 
problems (the right to use animals) and lack of reliability (animals have different 
physiology and metabolism than humans and therefore, which is difficult to 
translate into man) [8]. 
1.1.2. Alternative methods 
In 2001, the EU created the REACH (Registration, Evaluation and Authorization 
of Chemicals) program system to quantify the toxicity of existing and new 
chemical substances [10]. In the framework of the 7th revision to the EU 
Cosmetics Directive, an agreement to prohibit animal testing for cosmetic 
products which are already on the market after 2013 was reached [11]. 
Therefore, REACH favors the development of alternative methods to animal 
testing, which are regulated by the European Centre for the Validation of 
Alternative Methods (ECVAM) in Ispra, Italy [12]. In 2011, the EU through the 
ECVAM started the SEURAT-1 Research Initiative (‘Safety Evaluation 
Ultimately Replacing Animal Testing’) in order to establish a safe long-term 
chemical research strategy for humans which consists in repeated dose 
systemic toxicity testing of chemicals integrated in different projects, like e.g. 
SCR & Tox, HeMiBio, ESNATS, DETECTIVE, COSMOS, NOTOX, ToxBank 
and COACH [13]. 
SCR & Tox (‘Stem Cells for Relevant efficient extended and normalized 
TOXicology’) 
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HeMiBio (‘Hepatic Microfluidic Bioreactor’)  
ESNATS (‘Embryonic Stem cell-based Novel Alternative Testing Strategies’). 
DETECTIVE (‘Detection of endpoints and biomarkers for repeated dose toxicity 
using in vitro systems’)  
COSMOS (‘Integrated In Silico Models for the prediction of Human Repeated 
Dose Toxicity of COSMetics to Optimase Safety’)  
NOTOX (‘Predicting long-term toxic effects using computer models based on 
systems characterization of organotypic cultures’)  
ToxBank (‘Supporting Integrated Data Analysis and Servicing of Alternative 
Testing Methods in Toxicology’) 
COACH (‘Coordination of projects on new approaches to replace current 
repeated dose systemic toxicity testing of cosmetics and chemicals’)  
1.2. Liver 
The liver is a vital and complex organ which is located on the right side of the 
abdominal cavity. The liver plays an important role in the regulation of the 
metabolism of the human body. It is responsible for many vital tasks, such as 
glycogen storage, bile production and excretion, fat metabolism, plasma protein 
synthesis, as well as the endo- and xenobiotic metabolism [1, 14]. The liver is 
constituted by different types of cells which can be divided into two subgroups: 
parenchymal and non-parenchymal cells. The non-parenchymal cells include 
sinusoidal endothelial cells, Kupffer cells, hepatic stellate cells (Ito or fat-storing 
cells), pit cells (NK cells), hepatic dendritic cells, natural killer T cells (NKT) and 
biliary epithelial cells. The parenchymal cells are mainly consisting of 
hepatocytes [4]. 
1.2.1. Liver architecture 
The smallest structural unit of the liver is the lobule (Figure 1.1). The lobule has 
a hexagonal shape. At its corners are located the portal triads which are 
comprised of the bile duct, the hepatic artery and the portal vein. Blood enters 
the liver through the hepatic arteries and the portal veins and circulates among 
the sinusoidal vessels to the central vein which is located in the centre of the 
lobule. Hepatocytes are organized in plates consisting of 15-25 cells and their 
thickness differs the central vein and the borders of the lobule [4, 15, 16]. 
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Figure 1. 1 Basic representation of the physiology of the liver. (A) Schematic representation of 
the lobule and the hepatic plates. (B) Figure of the three-dimensional architecture of the liver 
between a portal triad and the central vein [15]. 
 
1.3. Hepatocytes 
Hepatocytes are functional cells of the liver and constitute 70-80% of the tissue 
volume of the whole organ [4]. Hepatocytes are responsible for the majority of 
the most important liver functions. To be functional, a different kind of cell, the 
endothelial cell are bordered as apical membrane, hepatocytes are limited by 
an apical and basal lateral membrane [17]. The apical membrane faces the bile 
canaliculi while the basal lateral membrane faces the sinusoidal vessels (Figure 
1.2.).  
 
Figure 1. 2 Schematic representation of hepatocytes with their respective apical and basal 
lateral membranes [18]. 
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1.3.1. Glucose production in hepatocytes 
The liver balances the blood glucose levels by controlling the absorption, 
storage and release of glucose. Excessive glucose in the liver is stored as 
glycogen and used as a long-term energy storage [19]. For fasting periods of 
more than one day, or intense exercise, glucose must be synthesized from non-
carbohydrate precursors, such as pyruvate, lactate, oxaloacetate, and amino 
acids via gluconeogenesis (Figure 1.3.). 
Gluconeogenesis takes places in three different compartments of the 
hepatocytes: the mitochondria, the cytosol and the endoplasmic reticulum. 
Pyruvate and oxaloacetate are produced from the partial breakdown of amino 
acids. In the mitochondria, oxaloacetate is formed by the carboxylation of the 
pyruvate. Oxaloacetate is reduced to malate by NADH which will be transported 
out of the mitochondria. Then, NAD+ triggers and oxidizes and oxaloacetate is 
transformed into phosphoenolpyruvate by phosphoenolpyruvate carboxykinase. 
Until the completion of the formation of glucose-6-phosphate, the following 
reactions take place in the cytosol. The formation of glucose takes place in the 
lumen of endoplasmic reticulum where glucose-6-phosphate is hydrolyzed by 
glucose-6-phosphatase. Finally, glucose is released to the cytosol by glucose 
transporters [20]. 
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Figure 1. 3 Schematic description of gluconeogenesis from lactate and pyruvate [21]. 
 
1.3.2. Ammonia detoxification in hepatocytes 
Ammonia is biosynthesized during the metabolism of amino acids. Hepatocytes 
are responsible for the detoxification of ammonia via ureagenesis. Thereby, 
they prevent the organism from suffering from hyperammonia and hepatic 
encephalopathy [22]. Ammonia is excreted as urea via the urea cycle (Figure 
1.4.) [23]. Then, aminotransferases convert amino acids into ammonia, before 
the amine group of glutamate is removed by glutamate dehydrogenase and 
glutaminase. Then, ammonia is converted into urea through the urea cycle by 
carbamoyl-phosphate-synthetase I, ornithine transcarbamylase, 
arginosuccinate synthetase, arginosuccinate lyase and arginase I [23]. 
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Figure 1. 4 Schematic representation of the ureagenesis pathway [23]. 
 
1.3.3. Biotransformation of drugs 
Hepatocytes are responsible for the metabolism of xenobiotic and endobiotic 
substances. The metabolism of these substances consists of three different 
phases. Phase I reactions include hydrolyses, reductions and oxidations [24]. 
Oxidative reactions are performed by the cytochrome P450 (CYP) enzyme 
family, which comprises thirty five different CYPs that are grouped in different 
subfamilies. The eighteen CYPs which make up the subfamilies 1-3 mainly 
participate in the metabolism of xenobiotic and endobiotic substances, like e.g. 
CYP3A4 (52%), CYP2D6 (30%), 2C9/10/19 (11%), CYP1A2 (4%) and CYP2E1 
(2%) [25, 26]. Phase II reactions are performed by transferases which conjugate 
the metabolic products from phase I. These reactions facilitate the modification 
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and conjugation of the xenobiotic substances and, in some cases, the 
conjugated metabolites can be substrates for specific transport proteins in order 
to facilitate the excretion [27]. Finally, phase III involves the elimination of 
conjugated metabolites via elution by transporter proteins located at the apical 
and at the basolateral membranes. The transporter proteins involving in the 
elution of the metabolism products are part of the ATP-binding cassette (ABC) 
family which is divided into several subfamilies, e.g.; ABCA, ABCB, ABCC, 
ABCD, ABCE, ABCG and ABCG [28, 29]. 
1.4. Hepatocyte culture 
Since the approval of the Directive for the Protection of Vertebrate Animals 
used for Experimental and other Scientific Purposes (86/609/EEC) in 1986 
researchers have focused on the establishment of long-term cultures of PHH in 
order to reduce animal testing [30]. Compared to animal models, hepatocytes 
dispose several advantages for the investigation of liver functions, such as 
controlled experimental conditions, reduction of material needed, easier 
analysis of the results, high throughput screening test can be performed, and a 
comparison of different species can be performed [31]. As mentioned before in 
the section 1.3, hepatocytes are limited by an apical and basal lateral 
membrane in their functional state [17]. However, hepatocytes have been 
traditionally cultured on monolayer (2D) cultures, which have been used to 
study drug metabolism and hepatotoxicity, spread losing their cuboidal shape 
generating a epithelial-mesenchymal transition during which the hepatocytes 
lose their polarity and architecture, lose many liver specific functions, and 
decrease cell viability during the time of culture (Fig. 1.5) [31, 32]. In order to 
improve hepatocytes attachment, culture plates are coated with an ECM protein. 
Several proteins have been used, for instance fibronectin which increases cell 
attachment and enables the organization of hepatocytes in cord-like structures 
[33]; however, collagen type I is the most commonly used [34]. In addition, fetal 
calf serum and formulations containing several hormones added to the medium 
culture have proved to influence on the cell survival of hepatocytes in culture 
[30]. Despite all these advances in hepatocyte culturing, long-term cultures of 
primary hepatocytes are needed in order to investigate drug metabolism and 
hepatotoxicity, which reduces the use of animals testing in drug development 
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[30] and allows the possibility of studying subchronic or even chronic toxicity 
[35]. In order to maintain hepatocytes polarity in long-term cultures, hepatocytes 
must be cultured in three dimensions (3D) which mimics the in vivo situation. 
Previous studies, have reported the importance of culturing cells in 3D 
compared to 2D [36]. In addition, hepatocytes cultured in 2D de-differentiate 
over the time. This de-differentiation state can be reversible by re-plating them 
in 3D [37]. Hepatocytes cultured in a sandwich disposition using two layers of 
hydrogels have shown a delay in the loss of hepatic architecture and 
polarization, and consequently hepatic dedifferentiation (Fig. 1.5). Collagen and 
Matrigel® are the most common gels used [30]. The second layer of gel allows 
the hepatocytes to form aggregates maintaining their cuboidal shape for a 
longer time, and consequently hepatocytes dedifferentiation is at least delayed 
[38, 39]. This means that hepatocytes maintain their hepatocytic phenotype and 
consequently their liver specific functions longer permitting long-term cultures. 
 
 
Figure 1.5 Schematic representation of PHH culture in 2D and 3D over 7 days and their 
respective fluorescence micrographs; where nuclei are in blue, actin fibers in red and dead cells 
are in green (autofluorescence). 
 
1.5. Tissue engineering 
Tissue engineering has been defined as ‘an interdisciplinary field that applies 
the principles of engineering and the life sciences towards the development of 
biological substitutes that restore, maintain, or improve tissue function’ [40]. The 
principle of tissue engineering is illustrated below (Figure 1.6), where primary 
cells are isolated from a human tissue and cultured in vitro until they proliferate 
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and seeded onto a carrier [41]. Then, the material containing the cells is 
implanted into the same patient in order to restore the damaged tissue. The 
carriers that are used in tissue engineering, are hydrogels, scaffolds, and 
bioreactors which enable the three-dimensional growth of the cells just like in 
the in vivo situation [15, 42]. PHH do not proliferate in vitro, nevertheless 
hydrogels, scaffolds, and bioreactors mimic the organotypic environmental 
conditions which allow preserving hepatocytic functions/phenotype during the 
time of culture. 
 
Figure 1. 6 Schematic representation of the basic principles of tissue engineering [41]. 
 
1.5.1. Hydrogels 
Hydrogels are hydrophilic, water-swollen polymers which form a network which 
can be modified concerning their nature and physical properties in order to 
mimic the extracellular matrix [43]. Therefore, several physical and biological 
properties based on degradation of the material, as well as mechanical and 
chemical properties, cell adhesion and biocompatibility must be taken into 
consideration during the design and selection of hydrogels [44]. Mechanical 
properties, such as porosity, must allow for the transport of signaling molecules, 
nutrients and metabolic products while maintaining the mechanical integrity of 
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the gels. Chemical properties are able to direct morphological cell changes by 
releasing specific signaling molecules or by degrading the matrix over time [45]. 
Based on their composition, hydrogels can be subdivided into natural and 
synthetic hydrogels (Table 1.1.). 
Table 1. 1 Overview of natural and synthetic hydrogels for the culture of PHH [33, 46, 47]. 
Polymer Observed benefits 
Natural hydrogels  
Collagen High biocompatibility, maintenance of viability and biotransformation 
capacity over 6 weeks 
Gelatin + Co-polymers High biocompatibility, maintenance of hepatocytes functions for 3 
weeks 
Matrigel
® 
Maintenance of viability and hepatocytes functions for 3 weeks  
Laminin High biocompatibility, maintenance of hepatic morphology and 
albumin secretion for 3 weeks 
Alginate Maintenance of cell polarity, high albumin production over 4 days 
Synthetic hydrogels  
PEG High reproducibility, high diffusion of liquids and particles 
          + PGLA Increase of urea synthesis and CYP3A4 activity compared to PEG 
hydrogel alone for 1 week 
          + Heparin High production of albumin and urea synthesis over 3 weeks 
          + RGD Formation of spheroids, maintenance of albumin and urea production 
over 4 weeks  
RAD16-I Maintenance of hepatic morphology, bile canaliculi formation, 
albumin secretion for 1 week 
 
Natural hydrogels are obtained from natural compounds, like e.g.; collagen, 
gelatin, Matrigel® (BD Biosciences, Billerica, MA, USA), laminin, fibronectin, and 
alginate. The major advantages of these hydrogels are their non-toxicity and 
their high biocompatibility as they are comprised of proteins and other ECM 
components, which present multiple membrane receptor sites [48]. Furthermore, 
hepatocytes cultured in hydrogels maintain their hepatic-specific functions and, 
in comparison to monolayer cultures, their hepatocyte dedifferentiation is at 
least delayed [38, 39, 49]. For instance, alginate beads are used in 
xenotransplantation as a cell therapy to bridge patients with acute liver failure 
until a suitable liver is available [50], and in bioreactors [51]. PHH cultured in 
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alginate beads have shown to delay the loss of hepatocytic activity over the 
time of culture in comparison to 2D cultures. Other hydrogel like laminin rich-gel 
maintains hepatocytes morphology and albumin secretion levels stable for 3 
weeks [47].  
As mentioned above, collagen and Matrigel® are the most commonly used gels 
[30]. Matrigel® is a gelatinous mixture of ECM components secreted by 
Engelbreth-Holm-Swarm sarcoma cells. On the other hand, collagen is the most 
common fibrous protein in the extracellular matrix and in the connective tissue 
in mammals. In humans, 16 different types of collagen can be found, but 
collagen type I, II, and III already form 80-90% of the total collagen in the body 
[52]. Traditionally, hepatocytes have been cultured between two layers of 
collagen (sandwich) [53, 54] (Figure 1.7 B). More recently, they have been re-
suspended in collagen gels [55, 56] (Figure 1.7 C), which allow for a reduction 
of the number of cells. The collagen that is used in cell cultures is either 
synthesized collagen type I or a collagen mixture mainly isolated from rat tails. It 
has been proved that collagen type III contributes to the hepatocytes spreading 
and maintenance of the phenotypic expression of the hepatocytes [57]. 
Therefore, rat tail collagen which is a mixture of collagens (I-III) [58] is widely 
used in hepatocyte cultures. Despite the advantages of culturing hepatocytes in 
rat tail collagen and Matrigel® these matrices present batch-to-batch differences.  
 
 
Figure 1. 7 Micrographs of collagen gel. (A) Scanning electron microscopy image of rat tail 
collagen fibers [59]. (B) PHH in collagen sandwich culture. (C) PHH in collagen gel culture. 
 
Synthetic hydrogels overcome batch-to-batch differences as they have a clearly 
defined composition. Therefore, the interest in synthetic hydrogels has 
increased in the last years. Furthermore, they can be customized to mimic the 
liver ECM by controlling the chain length and the density of the polymers and by 
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adding degradable linkages, adhesive peptide moieties, and other active factors 
[60, 61]. Polyethylene glycol (PEG) hydrogels have been extensively used in 
PHH culture enhancing hepatic functions related to monolayer cultures [62]. In 
addition, PEG gels can be combined with poly(lactic-coglycolic) acid (PLGA) or 
with biologically active entities from the hepatic ECM in order to benefit from cell 
adhesion and to improve hepatic-specific functions [63, 64]. Self-assembling 
peptides, like e.g. PuramatrixTM (3-D Matrix Inc., Waltham, MA, USA) are a 
category of peptides which undergo spontaneous assembling into ordered 
nanostructures which biochemical properties are similar to those of hepatic 
ECM. PHH cultures in self-assembling peptides maintain their activity over 3 
weeks [65, 66].  
In this research two synthetic hydrogels: 3D-Life Hydrogel (Dextran-PEG-
Hydrogel) (Cellendes GmbH, Reutlingen, Germany) and PEG hydrogels 
(Tecnalia, San Sebastián, Spain), which had not been tested for the culture of 
PHH beforehand were tested in comparison to collagen gel. However, both gel 
types were excluded as they did not allow for a homogeneous flow in the µ-slide 
channel.  
1.5.2. Scaffolds  
Scaffolds are porous solid biocompatible 3D materials which enable an 
interaction between the cells and the biomaterial, cell adhesion, ECM deposition, 
transport of nutrients and metabolic products [67]. Like hydrogels, scaffolds can 
be divided into natural and synthetic scaffolds as recently summarized by our 
group (Table 1.2.). 
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Table 1. 2 Overview of natural and synthetic scaffolds for the culture of PHH [46]. 
Polymer Observed benefits 
Natural scaffolds  
Alginate Cell-matrix interaction, high albumin and urea synthesis, CYP 
activities stable for 1 week 
Chitosan + 
Heparin/Collagen/Galactose 
Improved cell attachment, maintenance of hepatocytes 
morphology, albumin and urea secretion 
Synthetic scaffolds  
Polyvinyl alcohol Improved cell attachment, higher viability, albumin and urea 
synthesis over 3 weeks 
Polylactic acid Improved cell attachment, permeation of proteins and 
maintenance of hepatic functions 
Polystyrene Maintenance of hepatic morphology, bile canaliculi formation, 
albumin synthesis over 3 weeks. Better prediction of drug-induced 
toxicity 
 
Natural scaffolds favor cell-matrix communications and thereby enhance the 
biological performance of the cells over the time of culture [67]. These scaffolds 
are made up of proteins, polysaccharides or the combination of both such as 
chitin, alginate, chitosan/alginate (Figure 1.8), chitosan/heparin, chitosan/gelatin, 
etc. Hepatocytes that are cultured on these matrices maintain their metabolic 
activities over 15 days [68-70]. 
 
Figure 1. 8 Image of porous chitosan and porous chitosan/alginate. (A) Chitosan scaffold (x100 
magnification). (B) Chitosan/alginate scaffold (x100 magnification) [68]. 
 
Synthetic scaffolds are very common in research as they present a clearly 
defined composition and their properties can be modified according to the 
required functions [67]. In addition, depending on their fabrication and their use, 
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synthetic polymers are able to build foam disks (Figure 1.9 A) or fiber 
membranes (Figure 1.9 B) [71]. Polyvinyl alcohol (PVA) scaffolds allow for the 
formation of spheroid aggregates of hepatocytes favoring the production of 
albumin and urea over 3 weeks [72]. Due to its biodegradability, polylactic acid 
(PLA) is another common material for scaffolds. PLA scaffolds maintain their 
metabolic activities for 2 weeks [73]. Recently, a new scaffold which consists of 
polystyrene used in conventional tissue culture plates has been commercialized 
by Alvetex® (Reinnervate Ltd., Durham, UK). Hepatocytes that are cultured on 
these scaffolds preserve bile canaliculi morphology, metabolic activity and 
sensitivity to acetaminophen stimulation over 3 weeks [74].  
 
Figure 1. 9 Scanning electron microscopy images of foam and fibrous scaffolds. (A) PLA foam 
scaffold. (B) fibrous scaffold [71]. 
1.5.3. Bioreactors 
Liver tissue is one of the most irrigated tissues in the body. This high blood 
perfusion allows for the transport of nutrients, oxygen, endobiotic and xenobiotic 
substances and excreted metabolites by the hepatocytes [15, 75]. Traditional 
2D and 3D cultures present cells in static media differing from the in vivo 
condition [15]. In the last years, more and more sophisticated types of 
hepatocytes cultures, especially bioreactors, have been developed in order to 
create flow culture systems that mimic the in vivo conditions (Table 1.3). 
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Table 1. 3 Benefits and drawbacks of bioreactors and microfluidic devices applied for the 
culture of PHH [46]. 
Approach Cell No. 
(million) 
Demonstrated benefits Drawbacks Group 
Sartorius-Stedim 
Biostat
®
 Q-Plus 
bioreactor 
15-30 Maintenance of hepatic 
differentiation for more than 
4 weeks 
Protection from shear stress 
High cell number 
Costly equipment 
Animal Cell 
Technology, [51] 
Hollow-fiber 
bioreactor 
 100 Maintenance of CYP 
enzyme and transport 
protein expression and 
activity for up to 3 weeks 
Formation of bile canaliculi 
High cell number 
Low throughput 
Non-
microscopable 
Costly equipment 
Biochemical 
Engineering 
Institute, University 
of Saarland, [76] 
Multicompartment 
modular 
bioreactor 
˂ 1 Expression of detoxifying 
genes stimulated by medium 
flow 
Low throughput 
Non-
microscopable 
Centro 
Interdipartimentale 
di Ricerca, 
University of Pisa, 
[77] 
Perfused multi-
well plate 
˂ 1 In vivo-like testosterone 
metabolism and hepatic 
clerance 
High throughput 
Not commercially 
available 
Massachusetts 
Institute of 
Technology, [78] 
KITChip 
bioreactor 
˂ 10 Improvement of hepatic 
phenotype and up-regulation 
of hepatic marker genes in 
HepG2 cells 
Homogeneous medium flow 
and oxigen supply 
High cell number 
Low throughput 
Karlsruhe Institute 
of Technology and 
Institute for 
Biological 
Interfaces -1, [79] 
HepaChip
®
 ˂ 1 Maintenance of CYP 
activities and albumin 
secretion compared to 
hepatocyte monolayers 
Formation of bile canaliculi, 
cell-cell interaction 
Costly equipment 
Low throughput 
Naturwissenchaft-
liches und 
Medizinisches, 
University of 
Tübingen, [80] 
 
Bioreactors are ‘devices which biological and biochemical process develop 
under closely monitored and tightly controlled environmental and operating 
conditions (e.g.; pH, temperature, oxygenation, pressure, nutrient supply and 
waste removal)’ [81]. These devices create artificial culture conditions which are 
similar to the normal and pathological in vivo situation, and which enable a more 
realistic study of the cell-cell and cell-environment interactions [82]. Therefore 
bioreactors are excellent tools for long-time hepatic cultures, as PHH 
dedifferentiate by losing hepatic-specific functions after one week of culture [83]. 
The first commercially available bioreactors required large volumes and large 
numbers of PHH. Bioreactors with alginate-encapsulated hepatocytes (Figure 
1.10 A & B), in which alginate beads protect the hepatocytes from shear stress 
and maintain the hepatocytes alive over 4 weeks [51]. Another large-scale 
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bioreactor is the 3D hollow-fiber bioreactor (Figure 1.10 C) consists of three 
interwoven hollow-fibers which supply medium and gas to the cells [76]. This 
bioreactor maintains the hepatocytes alive for 3 weeks and enables the 
formation of bile canaliculi [76]. The major limitations of these systems are the 
high number of required cells, the high costs of the equipment, and the low 
number of laboratories in which they can be tested. 
 
 
Figure 1. 10 Images of different bioreactors. (A) Hepatocyte aggregates encapsulated in 
alginate beads. (B) Sartorius-Stedim Biostat
®
 Q-Plus Bioreactor system [51]. (C) Disposition of 
hollow fibers within the 3D bioreactor; light grey, medium capillaries; dark grey, gas capillaries 
[76]. 
 
Over the last decade, many efforts have been made in order to create new 
micofluidic systems which enable a reduction of the number of required cells 
and an increase of the throughput. One of these novel systems is the 
multichamber modular bioreactor which recreates different organs that can be 
used for the study of different diseases. This bioreactor has been 
commercialized under the name of Quasi-Vivo® (Kirkstall Ltd, UK). Hepatocytes 
are cultured on hydrogels or scaffolds in silicon chambers which induce the 
expression of metabolizing genes [77]. Another commercialized microfluidic 
system which is based on multi-well plates is the LiverChip (Zyoxel, Oxfordshire, 
UK). With this system, the hepatocytes are cultured on scaffolds in modified 
culture plates under continuous medium flow. This system allows for the 
implementation of high-throughput screening assays [78]. HepaChip® and 
KITChip are two microfluidic systems in which the cells are cultured in the 
cavities of the chips under continuous medium flow (Figure 1.11 A). HepaChip® 
recreates the liver sinusoid and allows for an active positioning of hepatocytes 
[80]. On the other hand, the KITChip system maintains high CYP activities for 
10 days (Figure 1.11 B) [79]. 
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Figure 1. 5 Images of different microfluidic systems. (A) HepaChip
®
 with detail view of one 
chamber, showing the three assembly gaps and the electrodes required for dielectrophoresis 
[80]. (B) KITChip with round cavities  and experimental setup for culture of primary hepatocytes 
in the KITChip bioreactor [79]. 
 
1.6. µ-slide microfluidic system 
PHH present a short life span when they are cultured in monolayer cultures. In 
this culture dispositon PHH lose their hepatocytic phenotype and become flat 
during the time of culture [31, 32] (Figure 1.12).  
 
Figure 1.12 Transmitted light micrograph of PHH on monolayer cultures: day 1 (A), day 7 (B), 
and day 14 (C). PHH are indicated by white arrows. 
 
In the last decades many efforts have been made in order to preserve 
hepatocyte phenotype in in vitro conditions by the development of hydrogels, 
scaffolds, and later bioreactors. Despite the fact that the bioreactors described 
in the previous point preserve hepatic differentiation by the expression of 
detoxifying genes, CYPs and transporter proteins, formation of bile canaliculi, 
and high albumin production, bioreactors are sophisticated and expensive 
devices difficult to handle and in many cases present low throughput compared 
to traditional cultures in 96-well plates [46]. Moreover, bioreactors are limited to 
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a small number of laboratories. Therefore, there is a need to create a simple 
microfluidic system which can be used by any laboratory. In this study we 
present a microfluidic system which uses a µ-slide (ibidi®, Munich, Germany) as 
a platform for culturing cells. The µ-slide is a commercially available plate for 
the culture of cells under a continuous flow. The µ-slide VI0.4 contains six 
channels and allows for the simultaneous creation of different flow cultures 
(Figure 1.13). The continuous flow system is relatively simple as only a 
conventional syringe pump is needed. The µ-slide is relatively small (30 
µl/channel), so, it only requires a low cell number (˂ 0.2*106 cells/channel). 
Moreover, it can be combined with different hydrogels depending on the study 
requirements and it is suitable for live cell imaging. Due to the small height of 
the channels, 3D cultures can only be performed by re-suspending cells in gels. 
This new conformation implies the previous characterization of the cells in static 
condition in order to have an adequate comparison. 
 
 
Figure 1. 13 Photograph of the µ-slide and the microfluidic culture. (A) ibidi
®
 µ-slide and (B) 
microfluidic culture system. 
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1.7. Aim 
This study investigates the behavior of PHH culture in different matrices under 
static and fluidic conditions. The precise aims of this research were: 
i. Analysis of MRP1 and MDR1/P-gp transporter membrane activity in 2D 
and 3D cultures. 
ii. Adaptation cell number in collagen gel cultures for down-screening 
purposes. 
iii. Characterization of PHH in static cultures, monolayer and 3D, over 28 
days of culture. 
iv. Reproduction of similar biological culturing conditions in a µ-slide which 
permit the maintenance of the differentiated state of primary human 
hepatocytes for seven days. 
v. Characterization of PHH in the microfluidic system.  
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2. Materials and Methods  
2.1. Materials 
2.1.1. Equipment 
Table 2. 1 Equipment  
Device  Company 
Auto sampler   Thermo Fisher Scientific, Dreieich, Germany 
Balance KERN ABJ   Kern & Sohn GmbH, Balingen, Germany 
Balance KERN PCB   Kern & Sohn GmbH, Balingen, Germany 
Centrifuge Megafuge 40R  Thermo Fisher Scientific GmbH, Osterode, 
Germany 
Clean Bench Safe 2020  Thermo Fisher Scientific GmbH, 
Langenselbold, Germany 
Digital Monochrome Printer 
P93DW 
 Mitsubishi Electric SDN. BHD, Senai, 
Malaysia 
Fluorescence Microscope 
EVOS-fl 
 Peqlab Biosysteme GmbH, Erlangen, 
Germany 
FLUOstar Omega  BMG Labtech, Offenburg, Germany 
LVis Plate   BMG Labtech, Offenburg, Germany 
Gel Stick Imager   Imaging Instruments GmbH, Chemnitz, 
Germany  
Hot plate IKA® RH basic 2  IKA®, Staufen, Germany 
Incubator BINDER  BINDER GmbH, Tuttlingen, Germany 
Perfusor® secura FT pum  B-Braun Melsungen AG, Melsungen, 
Germany 
Ligth Microscope Primo Vert  Carl Zeiss MicroImaging GmbH, Gottingen, 
Germany 
Microcentrifuge Fresco 17  Thermo Fisher Scientific GmbH, Osterode, 
Germany 
IPC peristaltic pump  IDEX Health & Science GmbH, Wertheim, 
Germany 
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Power Pack HC  Bio-Rad Laboratories GmbH, München, 
Germany 
Shaker DRS-12  LTF Labortechnik GmbH & Co. KG, 
Wasserburg, Germany 
Syringe Pump Perfusor 
Secura 
 B-Braun Melsungen AG, Melsungen, 
Germany 
Thermal Cycler Block 
ARKTIK 
 Thermo Fisher Scientific Oy, Vantaa, Finland  
Thermal Cycler Block Veriti®  Applied Biosystems (Life Technologies ™), 
Darmstadt, Germany  
Thermostat Lauda Alpha  Lauda Dr. R. Wobser GmbH & Co. KG, 
Lauda-Königshofen, Germany 
TSQ Quantum Discovery 
Max 
 Thermo Fisher Scientific, Dreieich, Germany 
Vortex mixer LSE™  Corning Incorporated, Corning, USA 
Water bath Aqualine AL25  Lauda Dr. R. Wobser GmbH & CO. KG, 
Lauda-Königshofen, Germany 
 
2.1.2. Consumables 
Table 2. 2 Consumables 
Product  Company 
Cellstart® Cell Culture Flasks 
25, 75 and 175 cm2 
 Greiner Bio-One GmbH, Frickenhausen, 
Germany 
Cellstart® Cell Culture Plates 24 
and 96 wells 
 Greiner Bio-One GmbH, Frickenhausen, 
Germany 
Falcon® Cell Culture Plates 6 
wells 
 Becton, Dickinson & Co. Ltd, Franklin 
Lakes, USA 
Cellstart® Tubes 15 and 50 ml  Greiner Bio-One GmbH, Frickenhausen 
Germany 
Costar® Stripette 5, 10 and 25 
ml 
 Corning Incorporated, Corning, USA  
Cryo Tube™ vials  Nunc, Roslkilde, Denmark 
Elbow Luer Connector  ibidi, Munich, Germany 
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Feather® Scalpel  Feather Safety Razor Co. Ltd, Osaka, 
Japan 
Fixo gum  Marabu GmbH & Co. KG, Bietigheim-
Bissingen, Germany 
Infusion  Oriplast, Neunkirchen-Saar, Germany 
Injection needles BD 
Microlance™ 3 
 Becton, Dickinson & Co. Ltd, S. Agustin 
del Guadix, Spain 
Injectomat®-Syringe 50 ml  Fresenius Kabi AG, Bad-Homburg, 
Germany 
Injection syringe 2, 10 and 20 
ml 
 B-Braun Melsungen AG, Melsungen, 
Germany 
Kinetex PFP analytical column  Phenomenex, Aschaffenburg, Germany 
Micro Tube 0.5 ml  Sarstedt Aktiengesellschaft & Co., 
Nümbrecht, Germany 
Multiply-Pro cup 0.2 ml  Sarstedt Aktiengesellschaft & Co., 
Nümbrecht, Germany 
Multiwell™ 6 wells  Becton, Dickinson & Co. Ltd., Franklin 
Lakes, USA 
Pasteur Pipettes 150 mm and 
230 mm, glass 
 Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
pH indicator Pehanon  Macherey-Nagel, Düren, Germany 
Pipette Tips 10 μl  Biozym Scientific GmbH, Oldendorf, 
Germany 
Pipette Tips 200 μl  Sarstedt Aktiengesellschaft & Co., 
Nümbrecht, Germany 
Ratiolab® Pipette Tips 1000 μl  Ratiolab GmbH, Dreieich, Germany 
Rotilabo®-microcentrifuge tubes 
1.5 ml 
 Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Safe-Lock Tubes 2.0 ml  Eppendorf AG, Hamburg, Germany 
Sterile Filter Millex® GP  Merck Millipore Ltd., Cork, Ireland 
Tygon® R3603  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
μ-slide VI0.4  ibidi, München, Germany 
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2.1.3. Chemicals 
Table 2. 3 Chemicals 
Chemical  Company 
3-(2-(N,N-diethylamino)ethyl)-7-
hydroxy-4-methylcoumarin 
 Sigma Aldrich Chemie GmbH, 
Steinheim, Germany 
3-(2-N,N-diethyl-N-
methylaminoethyl)-7-methoxy-4-
methylcoumarin 
 Sigma Aldrich Chemie GmbH, 
Steinheim, Germany 
3-Cyano-7-hydroxycoumarin  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
4-Methylumbelliferone  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
5-Carboxyfluorescein  Sigma Aldrich Chemie GmbH, 
Steinheim, Germany 
5(6)-Carboxy-2’,7’-
dichlorofluorescein diacetate 
 Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
7-Benzyloxy-
4(trifluoromethyl)coumarin 
 Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
7-Ethoxycoumarin  Fluka Chemie GmbH, Steinheim, 
Germany 
7-Ethoxy-4(trifluoromethyl)coumarin  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
7-Hydroxycoumarin  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
7-Hydroxy-
4(trifluoromethyl)coumarin 
 Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
7-Methoxy-
4(trifluoromethyl)coumarin 
 Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
Acetaminophen  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
Acetic acid  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Acetonitrile  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Materials and Methods 
Juan J. Martínez Sánchez                    Eberhard Karls Universität Tübingen                                  25 
Agarose  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany  
Ammonium chloride  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Boric acid  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Bovine Serum Albumin (BSA)  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Brij 35  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Bromophenol Blue sodium salt  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Calcium chloride  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Chloroform  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Collagenase P  Roche Diagnostics Deutschland 
GmbH, Mannheim, Germany 
Copper (II) sulphate  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Coumarin  Fluka Chemie GmbH, Steinheim, 
Germany 
D-(+)-glucose  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
Deoxyribonucleoside (dNTPs)  Axon, Kaiserslautern, Germany 
Diethylpyrocarbonate (DEPC)  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Dibenzylfluorescein  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
Diclofenac  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
Dimethylsufoxide (DMSO)  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
DMEM (10x)  Biochrom AG, Berlin, Germany 
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Easycoll Separating Solution  Biochrom AG, Berlin, Germany 
EGTA  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Ethanol  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Ethidium bromide  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Ethylendiamine tetraacetic acid 
disodium salt dehydrate 
 Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Folin & Ciocalteu’s phenol reagent  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
Fluorescein  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
Glucose oxidase  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
Glycerol  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Griseofulvin  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
Hydrochloric acid  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Isopropanol  VWR, Leuven, Belgium 
Magnesium chloride  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Magnesium chloride 25 μM  Axon, Kaiserslautern, Germany 
Monochlorobimane  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
Na-K Tartrate  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
N-Acetyl-L-Cysteine  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
N-(1-naphthyl)ethylenediamine 
dihydrochloride 
 Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
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O-Dianisidine Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
O-Phthalaldehyde  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
Ornithine  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
Peroxidase  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
Potassium chloride  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Probenecid  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
pUC 19  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Reaction buffer BD  Axon, Kaiserslautern, Germany 
Resazurin sodium salt  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
Resorufin sodium salt  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
Rhodamine 123  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
Salicylamide  Fluka Chemie GmbH, Steinheim, 
Germany 
Sodium carbonate  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Sodium chloride  VWR, Leuven, Belgium 
Sodium hydroxide  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Sodium-L-lactate  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
Sodium pyruvate  Sigma Aldrich Chemie GmbH, 
Steinheim,Germany 
Sulfuric acid  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
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Taq DNA Polymerase, 1000U   Axon, Kaiserslautern, Germany 
Tissue glue (Histoacryl)  B-Braun Melsungen AG, Melsungen, 
Germany 
peqGOLD TriFast™  Peqlab Biosysteme GmbH, Erlangen, 
Germany 
TRIS(hydroxymethyl)aminomethane  Applichem GmbH, Darmstadt, 
Germany 
Trypan Blue 0,5%   Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
Urea  Carl Roth GmbH & Co. KG, Karlsruhe, 
Germany 
 
2.1.4. Culture media and supplements 
Table 2. 4 Culture media and supplements 
Culture media and 
suplements 
 Company 
Amino acids  PAA Lab. GmbH, Traun, Austria 
DMEM high glucose, 4.5 g/L  PAA Lab. GmbH, Traun, Austria 
FCS  Gibco, Paisley, UK 
HEPES   PAA Lab. GmbH, Traun, Austria 
Hydrocortisone  Pfizer, Berlin, Germany 
Insulin (100E/ml)  Novo Nordisk, Bagsvaerd, Denmark 
L-Glutamine   PAA Lab. GmbH, Traun, Austria 
PBS  PAA Lab. GmbH, Traun, Austria 
Penicillin / streptomycin  PAA Lab. GmbH, Traun, Austria 
Sodium pyruvate   PAA Lab. GmbH, Traun, Austria 
Trypsin / EDTA   PAA Lab. GmbH, Traun, Austria 
Williams medium E   Sigma Aldrich Chemie GmbH, 
Steinheim, Germany 
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2.1.5. Items used (Kits) 
Table 2. 5 Kits 
Kit  Company 
First Strand cDNA Synthesis   Thermo Fisher Scientific GmbH, 
Schwerte, Germany 
Fluitest® LDH-L  Analyticon Biotechnologies AG, 
Lichtenfels, Germany 
Fluitest® GOT AST  Analyticon Biotechnologies AG, 
Lichtenfels, Germany 
Fluitest® GPT ALT  Analyticon Biotechnologies AG, 
Lichtenfels, Germany 
 
2.1.6. Software 
Table 2. 6 Software 
Program Company 
EndNote X5 Japone / Team LnDL, Thomas Reuters, San 
Francisco, USA 
Graph Pad Prism 5.01 GraphPad Software Inc., San Diego, USA 
ImageJ 1.45s National Institute of Health, Maryland, USA 
Intas Image software Imaging Instruments GmbH, Göttingen, 
Germany 
OMEGA software for 
FLUOstar, V1.10 
BMG Labtech, Offenburg, Germany 
Xcalibur 2.0.7. software Thermo Fisher Scientific, Dreieich, Germany 
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2.2. Methods 
2.2.1. Isolation of primary human hepatocytes 
The hepatocytes were isolated from resected liver capsules of tumor patients. 
Every patient had signed a consent form according to the ethical guidelines 
(368/2012BO2) of the Medical faculty of the Eberhard-Karls University Tübingen 
beforehand. PHH were isolated from resected livers by a two-step collagenase 
P perfusion technique (Figure 2.1.). 
 
     A                                                           B 
             
Figure 2. 1 Schematic representation of the two-step perfusion technique. (A) Step 1: Perfusion 
solution I was used to remove residual blood from the vessels and to warm up the tissue (B) 
Step 2: Perfusion solution II containing collagenase P was recirculated to digest the liver tissue 
structure [84]. 
 
Perfusion solution I (142 mM NaCl, 6.7 mM KCl, 10 mM Hepes, 240 mM EGTA, 
500 mM N-Acetyl-L-cysteine, pH = 7.4) was used to rinse the resected liver in 
order to eliminate the residual blood. In addition, it warmed up the liver tissue in 
order to facilitate the digestion of the tissue by the collagenase P. Then, 
perfusion solution II (67 mM NaCl, 6.7 mMl KCl, 100 mM HEPES, 0.5% albumin, 
4.8 mM CaCl·2H2O, pH = 7.6) containing collagenase P was recirculated in 
order to facilitate the digestion of the liver tissue structure by releasing the 
hepatocytes. The digested tissue was treated with ice-cold DPBS containing 20% 
FCS to stop the over-digestion of the tissue by the collagenase P. The 
hepatocytes that had been suspended in DPBS (20% FCS) were filtrated with a 
plastic funnel containing aseptic gauze to separate tissue debris. Finally, an 
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additional washing step was performed and the hepatocytes were re-suspended 
in DPBS. Cell viability was determined by Trypan blue exclusion using a 
Neubauer hematocytometer. If the cell viability was below 70%, the living cells 
were separated from the dead cells by density gradient centrifugation with 
Percoll® [75, 85]. 
2.2.2. Isolation of collagen from rat tails 
Collagen for cell culture was isolated from rat tails. The collagen tendons were 
isolated by breaking the skinned tails between every vertebra and pulling the 
tendons out. Then, the collagen fibers were air-dried and sterilized under UV 
radiation; 4.2 g of dried collagen fibers were stirred for 48 h in 500 ml of 1% 
acetic acid solution in order to solubilize the collagen. The protein concentration 
was determined by Lowry assay [86]. 
2.2.3. Optimization of the number of PHH in 3D 
Cells that are cultured in collagen gel dispose of a greater surface area than 
those cultured in monolayer. The optimization of the cell number was performed 
with Huh-7 cells, as their size is comparable to that of PHH. The optimal cell 
density was determined by seeding different cell numbers, from 100*103 cells to 
250*103 cells, in a 96-well plate. Then, resazurin conversion was performed in 
order to determine the highest viability among the different cell numbers.  
2.2.4. Cultivation of PHH 
In monolayer cultures, isolated hepatocytes were cultured in Williams’ medium 
E (10% FCS, 1 μM insulin, 15 mM HEPES, 0.8 μg/ml hydrocortisone, 100 U/ml 
penicillin and 100 μg/ml streptomycin, 1% L-glutamine, 1% non-essential amino 
acids, 1 mM sodium pyruvate) overnight on collagen-coated culture plates with 
a density of 1.5*105 cells/cm2 in monolayer cultures. Afterwards, the cells were 
washed with DPBS and the medium was replaced. In collagen sandwich 
cultures, 1:10 volume of 10× DMEM with phenol red and 1:100 volume of 
penicillin and streptomycin were dissolved in collagen stock solution. The pH 
was neutralized to 7.2-7.3 with NaOH. Each step was conducted on ice under 
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agitation in order to avoid collagen polymerization. The final collagen 
concentration was 2 mg/ml; 400 μl of collagen solution was spread into 10 cm2 
wells (6-well plates). After the polymerization of the gel, the PHH were seeded 
onto 6-well plates that have been prepared as described above. The cell density 
has to ensure cell confluence, 1.5*105 cells/cm2, as lower cell number favors the 
synthesis of nitric oxide [87]. Following the cell attachment, a second layer of 
collagen was added. In contrast to sandwich cultures, hepatocytes were re-
suspended at 5*103 cells/μl of collagen and 30 µl of PHH re-suspended in 
collagen was loaded in 96-well plates. After collagen polymerization, Williams’ 
medium E was added in both 3D cultures [88].  
2.2.5. Static cultures 
2.2.5.1. Collagen sandwich 
PHH are used in in vitro toxicity tests, however, monolayer cultures (2D) have 
limitations and several drug toxicities observed in vivo cannot be reproduced in 
2D in vitro models, like e.g. acetaminophen. Acetaminophen is a worldwide drug 
used due its therapeutic properties [2, 89], but an overdose can cause acute 
liver failure [3]. PHH were stimulated with acetaminophen over 72 h because it 
has been proved that hepatocytes can metabolize and show toxicity after the 
administration of acetaminophen during 72 h [74]. Therefore, PHH were 
cultured in monolayer and in collagen sandwich (3D) in order to investigate 
molecular differences during acetaminophen stimulation. 
2.2.5.1.1. Cell morphologies 
PHH were cultured over 11 days. Cell morphology was investigated by taking 
light micrographs with a microscope of PHH at different days, like e.g. day 1, 
day 3, and day 11. 
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2.2.5.1.2. Acetaminophen toxicity 
Primary human hepatocytes in 2D or 3D culture were treated with different 
concentrations acetaminophen (APA), like e.g., 0 mM, 0.25 mM, 0.5 mM, 1mM, 
5 mM and 10 mM, for 72 h. 
2.2.5.1.2.1. Live/Dead staining 
Calcein AM is a cell-permeable non-fluorescent dye which is converted into 
green fluorescent calcein by cytosolic esterases [90] in the cell cytoplasm at an 
excitation wavelength of λ = 485 nm and at an emission wavelength of λ = 530 
nm. In contrast, ethidium homodimer-1 can only enter cells with damaged 
membranes and produces a bright red fluorescent light when it interacts with 
the cell DNA at an excitation wavelength of λ = 530 nm and at an emission 
wavelength of λ = 645 nm. PHH were washed three times with DPBS. Then, the 
cells were stained with calcein AM (2μM) ethidium homodimer (4 μM) solution 
for 30 min and stored in a dark place. After the incubation time, the cells were 
washed three times with DPBS and pictures were taken with a fluorescence 
microscope [66, 91]. 
2.2.5.1.2.2. LDH, AST and ALT 
Cellular damage was investigated by measuring lactate dehydrogenase (LDH) 
[92], aspartate aminotransferase (AST) [93], and alanine aminotransferase (ALT) 
[94] leakage in the culture supernatants with a commercially available reaction 
kit (Analyticon Biotechnologies, Lichtenfels, Germany). For reference purposes, 
absorbance was measured at 570 and 690 nm with a plate reader. 
2.2.5.1.3. Gene expression of CYP2E1 and superoxide dismutase 1 (SOD1) 
PHH RNA was isolated by using TriFast reagent, a ready-to-use reagent for the 
separation of RNA from most DNA and protein in 2D cultures. In collagen gel 
cultures (3D), a collagen digestion was performed previously by incubating the 
cells for 10 min at 37 ºC, 5% CO2 with collagenase P (3 mg/ml) in DPBS. The 
quantity and the purity of RNA were determined by photometry which had been 
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obtained at 260 nm and 280 nm. The integrity of the RNA was checked by gel 
electrophoresis. Subsequently, the transcription of RNA to complementary DNA 
(cDNA) was performed with the First Strand cDNA Synthesis Kit (Fermentas). 
Then, reverse transcriptase PCR (RT-PCR) was performed. PCR is used to 
amplify a specific region of a DNA strand (the DNA target). It is based on 
thermal cycling and consists of cycles of repeated heating and cooling of the 
reaction in order to trigger DNA melting and the enzymatic replication of the 
DNA (see below). 
 
Figure 2. 2 Representation of the PCR cycle. (A) Denaturation (95 ºC); separation of parent 
strands in order to prepare of new strand synthesis. (B) Annealing (52-65 ºC); the primers bind 
to the parent strands. (C) Extension (72 ºC); addition of nucleotides to the growing end of the 
DNA strand (3’ end) by the Taq polymerase using the present strand as the template 
(http://users.ugent.be/~avierstr/principles/pcr.htm [30.05.2014l]).  
 
All cDNA samples were diluted to a final concentration of 10 ng/μl. The 
composition of the master mix was prepared as follows:  
Reaction Buffer B 10x (Mg2+ free)                  2.0 µl (1x)  
MgCl2 2.0 µl  
dNTP mix 0.5 µl  
Taq DNA polymerase 0.1 µl  
Forward Primer 1.0 µl  
Reverse Primer 1.0 µl  
Template *Variable  
H2O PCR Grade                                              *Variable  
Total volume 20 µl 
Finally, the PCR tubes were sealed and placed in the thermal cycler and the 
respective thermal cycle conditions were set. In general, PCR consists of a 
succession of 20-40 repeated temperature changes, named cycles (Fig. 2.3) 
PCR cycle consists of a denaturation, an annealing and an elongation step. The 
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temperatures and the time of each step vary according to the melting 
temperature of the used primers and polymerase. Before cycling, an 
initialization step at high temperature (> 90 ºC) is performed. A final elongation 
step followed by a hold step is performed after the cycling. [95].  
 
Figure 2. 3 Schematic representation of a program of the PCR cycle. 
 
In table 2.7 (see below), all used primers are listed with their respective size 
and annealing temperature. The primer annealing temperatures, number of 
cycles and the amount of used cDNA were optimized by testing various 
conditions. All generated PCR products were separated by electrophoresis gel 
stained with ethidium bromide. Gene expression was quantified by the ImageJ 
1.45 software (National Institute of Health, Maryland, USA). 
Table 2. 7 Primer sequences used in RT-PCR. 
Gen Forward / Reverse primer 5’→3’ AnnealingºC bp 
CYP 2E1 GAC TGT GGC CGA CCT GTT 
AC ACG ACT GTG CCC TGG G 
59 297 
SOD1 AAGGCCGTGTGCGTGCTGAA 
GTCTCCAACATGCCTCTCTTCATCC 
62 243 
GAPDH GTC AGT GGT GGA CCT GAC CT 
AGG GGT CTA CAT GGC AAC TG 
56 420 
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2.2.5.1.4. Protein expression of CYP2E1 and Superoxide Dismutase 1 
(SOD1) 
Western blot analysis, cells were collected by centrifugation and lysed in 0.5% 
Nonidet P40, 100 mM NaCl, 0.5% Deoxycholic acid, 10 mM EDTA and 10 mM 
Tris–HCl (pH 7.5) with the Complete Protease Inhibitor Cocktail (Roche, 
Mannheim, Germany) for 30 min in 2D cultures. In collagen gel cultures (3D), a 
collagen digestion was performed previously by incubating the cells for 10 min 
at 37 ºC, 5% CO2 with collagenase P (3 mg/ml) in DPBS. Lysates were 
centrifuged at 10,000 × g for 10 min at 4 °C. Protein concentration was 
determined by micro-Lowry [86]. The proteins were separated by SDS-PAGE 
and transferred to nitrocellulose membranes (Carl Roth, Karlsruhe, Germany). 
Membranes were blocked for 1 h with 5% semi-skimmed milk in 0.1% Tween-
20/PBS and incubated overnight with a primary antibody against SOD1 (mouse 
monoclonal antibody, Santa Cruz, Heidelberg, Germany), CYP2E1 and GAPDH 
(both rabbit polyclonal antibodies, Santa Cruz, Heidelberg, Germany). Proteins 
were visualized by secondary antibodies conjugated to horseradish peroxidase. 
Membranes were exposed to X-ray films and developed in a Curix 60 
Developing processor (Agfa, Cologne, Germany). All primary antibodies were 
diluted at a ratio of 1:1,000, and all secondary antibodies at a ratio of 1:5,000 in 
1% semi-skimmed milk in 0.1% Tween-20/PBS. Proteins were visualized using 
secondary antibodies conjugated to horseradish peroxidase. Membranes were 
exposed to X-ray films and developed in a Curix 60 Developing processor (Agfa, 
Cologne, Germany). The quantification was carried out with the ImageJ 1.45 
software (National Institute of Health, Maryland, USA). 
Table 2. 8 First antibody used in Western blot 
Antibody Isotype Dilution Size [KD] Company 
CYP 2E1 Rabbit IgG1 1:1000 57 Santa Cruz, Heidelberg, 
Germany 
SOD1 Mouse IgG1 1:1000 24 Santa Cruz, Heidelberg, 
Germany 
GAPDH Rabbit IgG1 1:1000 37 Santa Cruz, Heidelberg, 
Germany 
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Table 2. 9 Secondary antibody used in western blot 
Antibody Dilution Company 
Goat anti rabbit IgG1 1:5000 Santa Cruz, Heidelberg, Germany 
Goat anti mouse IgG1 1:5000 Santa Cruz, Heidelberg, Germany 
 
2.2.5.1.4. MRPs gene expression 
The isolation, quantification, and purity check of RNA, as well as RT-PCR were 
performed as CYP2E1 and SOD1 gene expression (Section 2.2.5.1.3). In table 
2.10. (see below), all the primers that were used in these experiments are listed 
with their respective size and annealing temperature. Gene expression was 
quantify by the ImageJ 1.45 software (National Institute of Health, Maryland, 
USA). 
Table 2. 10 Primer sequences used for the RT-PCR. 
Gen Forward / Reverse primer 5’→3’ Annealing ºC bp 
MRP1 TTG GAT GAG GCC ACG GCA GC 
CTG GGG CTC ACA CCA AGC CG 
58 247 
MRP2 AGA CGC AGT CCA GGA ATC ATG C 
CAC GTG GAG AAG CTG CCA GGG 
61 171 
MRP3 CTG CCC CAG TTA ATC AGC AAC CTG 
GCG CTT GGG GTT CAG GGC TTT 
60 405 
MRP4 TGA TCA CAG CCA GCC GCG TG 
ACG GGG CCG ACC ACA GCT AA 
60 307 
 
2.2.5.1.5. MRP1 transporter activity assay 
Multidrug resistance-associated protein 1 (MRP1) transport activity was 
investigated by using a modified carboxyfluorescein efflux assay [96]. Cells 
were seeded in 96-well plates; washed 3 times with DPBS and incubated with 4 
μM of 5(6)-carboxy-2′,7′-dichlorofluorescein diacetate (5-CFDA) for 30 min. 
Wells without cells were used as background subtraction for 2D and 3D cultures. 
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The cells were washed 3 times with DPBS and a fluorescence measurement 
was conducted in order to determine the amount of 5-CFDA that had been 
taken up and metabolized to 5-carboxyfluorescein succinimidyl ester (5-CFSE) 
by the hepatocytes. Next, the cells were re-incubated with DPBS containing 11 
mM glucose for 60 min. Supernatants were collected 5, 10, 20, 30, and 60 min 
after the incubation and transferred to a new 96-well plate in order to determine 
the amount of 5-CFSE that is eluted by the hepatocytes. The quantification was 
carried out by using a linear calibration curve of the linear standard curve (Fig. 
2.4). 
 
Figure 2. 4 Standard curve of 5-CFSE. 
 
2.2.5.1.6. Quantification of Acetaminophen 
The quantification of remaining acetaminophen was performed by LC/MS 
analysis. The samples were precipitated with twice the volume of acetonitrile 
supplemented with the internal standard (1 μM griseofulvin). After vigorous 
shaking (10 sec) and centrifugation for 5 min with 5000 g at RT, the particle-free 
supernatants were subjected to LC–MS/MS. The HPLC system consisted of an 
LC Plus pump and an auto sampler. Mass spectrometry was performed on a 
TSQ Quantum Discovery Max triple quadrupole mass spectrometer equipped 
with an electrospray interface and connected to a PC with the Xcalibur 2.0.7 
standard software (Thermo Fisher Scientific, Dreieich, Germany). The flow rate 
of the HPLC pump was set to 600 μl/min and the compounds were separated 
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on a Kinetex PFP, 2.6 μm, 50 × 2.1 mm analytical column with Krudkatcher. 
The analytes were separated by gradient elution with acetonitrile/0.1% formic 
acid as the organic phase (A) and 10 mM ammonium acetate / 0.1% formic acid 
as the aqueous phase (B) (%A (t (min), 0 (0–0.2)–97 (0.8–1.8)–0 (2.0–4.0)). 
The MS–MS identification of characteristic fragment ions was performed using 
the following set of parameters: ion source temperature: 350 °C, capillary 
voltage: 3.8 kV, collision gas: 0.8 mbar argon, spray and sheath gas: 20 and 8 
(arbitrary units), respectively. The stable product ions with the highest S/N ratio 
were used to quantify the test item in the selected reaction monitoring mode 
(SRM). The transitions used for the analysis were m/z 152.1 to m/z 65.0 and 
m/z 93.0 (acetaminophen) and m/z 353.0 to m/z 215.0 (griseofulvin, internal 
standard). 
2.2.5.2. Collagen gels 
One of the major problems to culture PHH is the short life span in 2D cultures 
2.2.5.2.1. Cell morphology studies 
PHH were cultured over 28 days. Cell morphology was investigated by taking 
light micrographs with a microscope of PHH at different days, like e.g. day 1, 
day 7, day 14, day 21, and day 28. 
2.2.5.2.2. Cell viability 
2.2.5.2.2.1. Live/Dead staining 
Live/dead staining was performed as described in the section 2.2.5.1.2.1. 
2.2.5.2.2.2. Resazurin conversion 
Resazurin conversion is a fluorescence assay which can be used to measure 
proliferation, viability and toxicity (indirectly) in cells. The assay is based on the 
ability of living cells to convert a redox dye (resazurin) into an end product 
(resorufin). This conversion involves a colorimetric change which can be 
measured with fluorescence-based measuring instruments [97, 98]. 
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Fluorescence was monitored at an excitation wavelength of 530-560 nm and an 
emission wavelength of 590 nm.  
 
Figure 2. 5 Chemical structure of resazurin sodium salt and resorufin sodium salt. 
 
The culture mediums were removed from the cells and washed twice with 
DPBS. Then the cells were incubated with 1:10 resazurin stock solution in plain 
medium (0.025%) in an incubator at 37 °C, 5% CO2 for 2 h. Wells without cells 
were used as background subtraction for 2D and 3D cultures. The fluorescence 
was measured at an excitation wavelength of λ = 544 nm and at an emission 
wavelength of λ = 590-610 nm. The average background was subtracted from 
the other data [99].  
2.2.5.2.3. Glucose production 
Glucose production was studied through the gluconeogenesis process which 
takes mainly place in the liver and is based on the production of glucose from 
pyruvate.  
 
Figure 2. 6 Glucose cycle. (A) Schematic representation of the glucose cycle 
(http://www.uv.es/marcof/Tema17.pdf [28.10.2013]). (B) Glucose detection in the supernatant. 
 
PHH were washed three times with DPBS. Then, one part of the cells was 
incubated with 150 μl (96-well plate) reaction buffer (1 mM MgCl2 and 1 mM 
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sodium pyruvate in DPBS), while the other part was incubated with 150 μl of 11 
mM L-lactate reaction buffer for 24 h at 37 ºC, 5% CO2. Wells without cells were 
used as background subtraction for 2D and 3D cultures. After 24 h, 100 μl of 
culture supernatants were transferred to a new 96-well plate for glucose 
quantification. Simultaneously, a glucose standard curve was prepared in the 
same 96-well plate. Then, 150 μl of GLOX solution (250 mM TRIS, 0.2 mM 
EDTA, 0.04% glucose oxidase, 0.01% o-Dianisidine, 0.007% peroxidase, pH = 
8.0) was added in every well and incubated for 2 h at 37 ºC, 5% CO2. After the 
incubation time, the absorption was measured at a wavelength of λ = 425 nm 
with a plate reader [100]. 
 
 
Figure 2. 7 Glucose standard curve. 
 
2.2.5.2.4. Ammonia detoxification 
The urea production was measured by the photometric determination of urea, a 
decomposition product of ammonia in PHH. PHH were washed three times with 
DPBS. Then, the cells were incubated with 100 μl (96-well plate) of 300 mM 
NH4Cl in reaction buffer (1 mM MgCl2 and 1 mM sodium pyruvate in DPBS) for 
24 h at 37 ºC, 5% CO2. Wells without cells were used as background 
subtraction for 2D and 3D cultures. After 24 h, 80 μl of culture supernatant were 
transferred to a new 96-well plate for urea quantification. Simultaneously, a urea 
standard curve was prepared in the same 96-well plate. Then, 60 μl of o-
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Phthalaldehyde solution (1.5 mM o-Phthalaldehyde, 4 mM Brij-35, 0.75 M 
H2SO4) and 60 μl of NED’s reagent (2.3 mM N-(1-naphthyl) 
ethylenediaminedihydrochloride, 0.08 M boric acid, 4 mM Brij-35, 2.25 M H2SO4) 
were added in each per well and incubated for 2 h at 37 ºC, 5% CO2. After the 
incubation time, the absorption was measured at a wavelength of λ = 460 nm 
with a plate reader [101, 102]. 
 
 
Figure 2. 8 Urea standard curve. 
 
2.2.5.2.5. Enzymatic activity of Cytochrome P450 
2.2.5.2.5.1. Cytochrome P450 gene expression 
The isolation, quantification and purity check of RNA, as well as RT-PCR were 
performed as CYP2E1 and SOD1 gene expression (Section 2.2.5.1.3). In table 
2.11. (see below), all the primers that were used in these experiments are listed 
with their respective size and annealing temperature. Gene expression was 
quantified by the ImageJ 1.45 software (National Institute of Health, Maryland, 
USA). 
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Table 2. 11 Primer sequences used in RT-PCR. 
Gen Forward / Reverse primer 5’→3’ Annealing ºC bp 
CYP 1A1 TTC GTC CCC TTC ACC ATC 
CTG AAT TCC ACC CGT TGC 
55 302 
CYP 1A2 TCG ACC CTT ACA ATC AGG TGG 
GCA GGT AGC GAA GGA TGG G 
60 254 
CYP 2A6 CAA CCA GCG CAC GCT GGA TC 
CCA GCA TAG GGT ACA CTT CG 
60 423 
CYP 2B6 ATG GGG CAC TGA AAA AGA CTG A 
AGA GGC GGG GAC ACT GAA TGA C 
62 283 
CYP 2C8 CAT TAC TGA CTT CCG TGC TAC AT 
CTC CTG CAC AAA TTC GTT TTC 
60 147 
CYP 2C9 CTG GAT GAA GGT GGC AAT TT 
AGA TGG ATA ATG CCC CAG AG 
59 308 
CYP 2D6 CTT TCG CCC CAA CGG TCT C 
TTT TGG AAG CGT AGG ACC TTG 
59 222 
CYP 2E1 GAC TGT GGC CGA CCT GTT 
AC ACG ACT GTG CCC TGG G 
59 297 
CYP 3A4 ATT CAG CAA CAA GAA CAA GGA CA 
TGG TGT TCT CAG GCA CAG AT 
64 314 
GAPDH GTC AGT GGT GGA CCT GAC CT 
AGG GGT CTA CAT GGC AAC TG 
56 420 
 
2.2.5.2.5.2. Phase I (CYPs) and phase II enzymatic activity 
The enzymatic activity was analyzed with a modified fluorescence-based 
method [103, 104]. PHH were incubated for 2 h at 37 ºC with different 
substrates diluted in plain medium (Tables 2.12. and 2.13.). The cells converted 
to a metabolite. These conversions produced a change in fluorescence which 
was measured with a plate reader. Moreover, in the phase I substrates, 15 μl/ml 
salicylamide buffer (100 μM in DMSO), 10 μl/ml probenecid buffer (200 mM in 
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DMSO) and 1 μl/ml buffer dicoumarol buffer (10 mM in DMSO) were added to 
prevent spontaneous fluorescence decay. Wells without cells were used as 
background subtraction for 2D and 3D cultures.  
Table 2. 12 Substrates used during the study of phase I.  
Reaction Substrate Substrate 
conc. 
Metabolite Excitation/Emission  
CYP 1A1/2 7-EC 25 μM HC 355 nm/460 nm 
CYP 2A1 7-ER 7.5 μM Res 544 nm/590 nm 
CYP 2A6 Cou 50 μM HC 355 nm/460 nm 
CYP 2B6 EFC 30 μM HFC 355 nm/520 nm 
CYP 2C8/9 DBF 12.5 μM FL 485 nm/520 nm 
CYP 2D6 AMMC 10 μM AHMC 355 nm/460 nm 
CYP 2E1 MFC 5 μM HFC 355 nm/520 nm 
CYP 3A4 BFC 5 μM HFC 355 nm/520 nm 
 
Table 2. 13 Substrates used during the study of phase II.  
Reaction Substrate Substrate 
conc. 
Excitation / Emission  
Resorufin conjugation Res 25 μM 355 nm/460 nm 
GSH conjugation MCB 7.5 μM 544 nm/590 nm 
UGT activity 4-MU 50 μM 355 nm/460 nm 
HC conjugation HC 30 μM 355 nm/520 nm 
HFC conjugation HFC 12.5 μM 485 nm/520 nm 
FL conjugation FL 10 μM 355 nm/460 nm 
AHMC conjugation AHMC 5 μM 355 nm/520 nm 
CHC conjugation CHC 5 μM 355 nm/520 nm 
 
The measured values were quantified by using their respective standard curves.  
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Figure 2. 9 Standard curves of the studied enzymatic products. 
 
2.2.5.2.6. Efflux assays 
2.2.5.2.6.1. Gene expression of the transporter channels 
The isolation, quantification and purity check of RNA, as well as RT-PCR were 
performed as CYP2E1 and SOD1 gene expression (Section 2.2.5.1.3). In table 
2.14 (see below), all the primers that were used in these experiments are listed 
with their respective size and annealing temperature. Gene expression was 
quantified by the ImageJ 1.45 software (National Institute of Health, Maryland, 
USA). 
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Table 2. 14 Primer sequences used for the RT-PCR. 
Gen Forward / Reverse primer 5’→3’ Annealing ºC bp 
NTCP CCC TCA CGG CCT TTG TGC TGG 
ACT GTG ACG GCC ACA CTG CAC 
60 394 
OCT1 CTG GTC GAA ATC CCG GGG GC 
CAG GCC CAA CAC CGC AAA CAA 
60 363 
MDR1 ATC CGG GCC GGG AGC AGT CA 
ATT CCG ACC TCG CGC TCC TTG 
61 252 
MDR2 GGA ATT GGT GAC AAG GTT GG 
ATA CCA GAA GGC CAG TGC AT 
61 395 
MDR3 TGG CCA GGC TGC CCC ATG TA 
CAA CCA GGG CCA CCG TCT GC 
61 245 
MRP1 TTG GAT GAG GCC ACG GCA GC 
CTG GGG CTC ACA CCA AGC CG 
58 247 
MRP2 AGA CGC AGT CCA GGA ATC ATG C 
CAC GTG GAG AAG CTG CCA GGG 
61 171 
MRP3 CTG CCC CAG TTA ATC AGC AAC CTG 
GCG CTT GGG GTT CAG GGC TTT 
60 405 
MRP4 TGA TCA CAG CCA GCC GCG TG 
ACG GGG CCG ACC ACA GCT AA 
60 307 
MRP5 GGG CCA GAC GCT GCT TCC CT 
AAG CGA CCA AGA CCG CAC GAT 
61 228 
MRP6 TTG GAA AAT CCA ACA GGG AAC GCC 
CTG CTG GGC AGC GTT GGT AGC 
62 190 
BSEP GGT CGT TGG CTG TGG GTT GC 
AGC ACG CCT GGC TGG GCT AT 
61 266 
BCRP CTC CGA GCG CAC GCA TCC TG 
AGC TGT CGC GGG GAA GCC AT 
61 153 
GAPDH GTC AGT GGT GGA CCT GAC CT 
AGG GGT CTA CAT GGC AAC TG 
56 420 
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2.2.5.2.6.2. Transporter channel activity 
2.2.5.2.6.2.1. Multidrug resistance-associated protein-1 
MRP1 transport activity was investigated as described in the section 2.2.5.1.5. 
2.2.5.2.6.2.2. Multidrug resistance P-glycoprotein  
Multidrug resistance P-glycoprotein (MDR1/P-gp) transport activity was 
investigated by using a modified rhodamine 123 efflux assay [96]. Cells were 
seeded in 96-well plates, washed 3 times with DPBS, and incubated with 3 μM 
of rhodamine 123 for 30 min. Wells without cells were used as background 
subtraction for 2D and 3D cultures. The cells were washed 3 times with PBS 
and a fluorescence measurement was conducted in order to determine the 
amount of rhodamine 123 that had been taken up by the hepatocytes. The cells 
were re-incubated in DPBS containing 11 mM glucose for 60 min. Supernatants 
were collected 5, 10, 20, 30, and 60 min after the incubation and transferred to 
a new 96-well plate in order to determine the amount of rhodamine 123 eluted 
by the hepatocytes. The quantification was carried out by using a linear calibra-
tion curve of the linear standard curve. 
 
Figure 2. 10 Standard curve of Rhodamine 123. 
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2.2.5.7. Drug toxicity 
PHH that were seeded in 96-well plates were washed twice with DPBS. Then, 
they were stimulated for 72 h with various concentrations of acetaminophen (0-
10 mM in medium) and diclofenac (0-1 mM in medium). Wells without cells were 
used as background subtraction for 2D and 3D cultures. The experimental set 
up was as follows: 
 
 
Figure 2. 11 Representation of the experimental set-up. (A) Acetaminophen, (B) Diclofenac. 
 
After the stimulation, the cell supernatants were removed. The viability of the 
cells was measured as described in section 2.2.5.2.2.2 (resazurin conversion) 
and the results were indicated as % of the untreated control. 
2.2.6. Flow culture 
2.2.6.1. Perfusion assays 
Perfusion assays were performed in order to determine an appropriate flow rate 
which allows for a homogeneous diffusion of the medium in the μ-slide channels. 
Collagen gel (2 mg/ml; Section 2.2.2) was loaded into the μ-slide channels, first 
without cells, and then with cells. Resazurin sodium salt in DPBS (0.025%) was 
pumped through the channels by using a syringe pump with different flow rates: 
100 μl/h, 800 μl/h, 2 ml/h. 
Materials and Methods 
Juan J. Martínez Sánchez                    Eberhard Karls Universität Tübingen                                  49 
2.2.6.2. Cell culture 
Isolated PHH were resuspended in collagen gel (2 mg/ml) with a density of 
5*103 cells/μl. The μ-slide channels and the 96-well plate were loaded with 30 μl 
of collagen gel containing PHH. After the collagen polymerization, µ-slide 
system was set up. The microfluidic system has the following components (Fig. 
2.12): 
 µ-slide; used as a cell culture platform and fixed at the height of 14.5 cm. 
 Falcon tubes (50 ml); used as medium reservoirs and fixed at the height 
of 11 cm. 
 Luer connectors which connect the µ-slide with the tubing. 
 Y connectors which connect the tubing. 
 Tubing. 
 Syringe pump; used as flow supplier. 
 Falcon tubes (15 ml); used to collect the eluted medium. 
 
 
Figure 2. 12 μ-slide flow system. 
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2.2.6.3. Cell morphology studies 
PHH were cultured over 7 days. Cell morphology was investigated by taking 
light micrographs with a microscope of PHH at day 1 and day 7. 
2.2.6.4. Cell viability 
2.2.6.4.1. Live/Dead staining 
After day 1 and day 7 of culture, the μ-slide was removed from the µ-slide 
system. Then, collagen gels containing PHH were removed from the μ-slide and 
placed in a 24-well plate. Live/dead staining was performed as described in the 
section 2.2.5.1.2.1. 
2.2.6.4.2. Resazurin conversion 
After day 1 and day 7 of culture, the μ-slide was removed from the system. 
Then, collagen gels containing PHH were removed from the μ-slide and placed 
in a 96-well plate in order to make a proper comparison with the static cultures. 
Resazurin conversion was measured as described in the section 2.2.5.2.2.2. 
2.2.6.5. Glucose production 
After day 1 and day 7 of culture, the μ-slide was removed from the system. 
Then, collagen gels containing PHH were removed from the μ-slide and placed 
in a 96-well plate in order to make a proper comparison with the static cultures. 
Glucose production was measured as described in the section 2.2.5.2.3. 
2.2.6.6. Enzymatic activity of CYP2E1 and CYP3A4 
After day 1 and day 7 of culture, the μ-slide was removed from the system. 
Then, collagen gels containing PHH were removed from the μ-slide and placed 
in a 96-well plate in order to make a proper comparison with the static cultures. 
CYP2E1 was investigated by stimulating the hepatocytes with 100 µM of 
acetaminophen and CYP3A4 with 10 µM of diclofenac. The quantification of the 
remaining acetaminophen and diclofenac; as well as of their respective 
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products acetaminophen-sulfate and hydroxydiclofenac were performed by 
LC/MS analysis as described in the section 2.2.5.1.6. 
2.2.6.7. Drug toxicity 
After day 1 and day 7 of culture, the μ-slide was removed from the µ-slide 
system. Then, collagen gels containing PHH were removed from the μ-slide and 
placed in a 96-well plate in order to make a proper comparison with the static 
cultures. Hepatocytes were stimulated for 72 h with various concentrations of 
acetaminophen (0-10 mM in medium) and diclofenac (0-1 mM in medium). 
Wells without cells were used as background subtraction for 2D and 3D cultures. 
The viability of the cells was measured as described in section 2.2.5.2.2.2 
(resazurin conversion) and the results were shown as % of the untreated control. 
2.2.7. Statistics 
All results were expressed as mean ± SD. For statistical analysis, the GraphPad 
Prism software was used. When two test conditions were analyzed, a t-test for 
spot checks was carried out. When three or more test conditions were observed, 
the statistical analysis was carried out by one-way analysis of variance (ANOVA) 
and by Bonferroni’s multiple t test, followed by a multiple comparison test. The 
GraphPad Prism software was used to perform statistical analysis, p < 0.05 was 
set as a threshold for statistical significance.  
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3. Results 
3.1. Static cultures 
3.1.1. Collagen sandwich 
3.1.1.1. Cell morphology studies 
PHH morphology was investigated by observing the cells under the microscope 
(Fig. 3.1). PHH that were cultured with the 3D collagen sandwich technique 
maintained a hexagonal shape over the time of culture. However, PHH in 2D 
cultures gained a planar and fibroblast-like appearance after having been 
cultured for several days. In addition, after day 11 of culture, hepatocytes in 2D 
died and detached from the plate. 
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Figure 3. 1 PHH preserve their morphology over the cell culture period in collagen gel, day 1, 
day 3 and day 11 (x100 magnification). (A) 2D culture; (B) 3D sandwich culture [105]. 
 
3.1.1.2. Acetaminophen toxicity 
3.1.1.2.1. Live/Dead staining 
PHH cultures on collagen monolayer and collagen sandwich were stimulated 
with different concentrations of APA for 72 h. An increased number of dead 
cells were observed in 3D, but not in 2D cultures (Fig. 3.2 A). The quantification 
of the fluorescence signal revealed that the drug sensitivity was concentration-
dependent (Fig. 3.2 B). The treatment with 1 mM, 5 mM and 10 mM 
acetaminophen led to a significant increase of the fluorescence intensity (**p < 
0.01; *p < 0.001) (up to 40%, 40% and 50%, respectively). This corresponded 
to an increase of dead cells in comparison to the untreated cells. Even at 10 
mM acetaminophen, no increase in the number of dead cells was detectable in 
the standard 2D culture. The untreated control in each culture condition was set 
to 1.  
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Figure 3. 2 Microscopic observation of PHH in standard 2D and in 3D sandwich cultures after 
the treatment with varying concentrations of acetaminophen for 72 h (A). Quantification of dead 
cells stained by a fluorescent dye in each culture condition, the untreated control in each culture 
condition was set to 1 (B). **p < 0.01; *p < 0.001, N=3, n=2 [105]. 
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3.1.1.2.2. LDH, AST and ALT 
Concentration-dependent release of LDH (Fig. 3.3.A), AST (Fig. 3.3.B), and 
ALT (Fig.3.3.C) was detected in 3D cultures treated with acetaminophen. The 
incubation with acetaminophen in 3D cultures led to a dose-dependent, but 
statistically insignificant increase of LDH, AST, and ALT levels at 72 h 
compared to 2D cultures. The release of LDH, AST, and ALT was measured in 
a fluorescence reader. In each culture condition, the untreated control was set 
to 1. 
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Figure 3. 3 Comparison of amount of LDH, AST, and ALT released by PHH after the treatment 
with acetaminophen for 24 h and 72 h in 2D and 3D cultures. The release of LDH (A), AST (B) 
and ALT (C) was measured in a fluorescence reader. The untreated control was set to 1 [105]. 
 
3.1.1.3. Gene and protein expression of CYP2E1 and SOD1 
CYP2E1 is involved in the formation of NAPQI, the reactive intermediate of 
acetaminophen. Therefore, the gene and protein expression of the CYP2E1 
after the treatment with acetaminophen were compared between both culture 
models. No differences between 2D and 3D cultures were detected in the gene 
expression of CYP2E1 (Fig. 3.4 A and 3.4 B). At protein level, a concentration-
dependent increase of the CYP2E1 was only observed in the 3D culture (Fig. 
3.4 C). The quantification of the Western blot revealed a significant increase (*p 
< 0.05, **p < 0.01) in the expression of CYP2E1 after 72 h of up to 230%, 260%, 
and 310% in the presence of 1 mM, 5 mM and 10 mM acetaminophen in 3D 
cultures, while the protein expression remained unaffected in 2D (Fig. 3.4.D). 
Like CYP2E1, the antioxidant enzyme SOD1 gene expression indicated no 
difference between 2D and 3D cultures (Fig. 3.4 E and 3.4 F). However, the 
SOD1 protein expression gradually decreased after the treatment with 
acetaminophen and was undetectable after a treatment of 24 h with 10 mM 
acetaminophen in 3D cultures. In 2D cultures however, the SOD expression 
remained unaffected by the treatment with acetaminophen. 
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N = 2 
Results 
Juan J. Martínez Sánchez                    Eberhard Karls Universität Tübingen                                  59 
 
       N = 2 
Figure 3. 4 Gene and protein level expression of CYP2E1 and SOD1. Semi-quantitative PCR 
blots of CYP2E1 (A, B) and SOD1 (E, F) after acetaminophen stimulation were compared to 
their respective control in 2D and 3D cultures. Data are shown as x-fold of control normalized to 
GAPDH; one-way ANOVA, *p ˂ 0.05. Representative blots from two different experiments at 72 
h were detected by Western blot. Protein levels of CYP2E1 (C, D) and of SOD1 (G, H) after the 
treatment with acetaminophen were compared to their respective control in 2D and 3D cultures. 
Data are shown as x-fold of control normalized to GAPDH; one-way ANOVA, *p ˂ 0.05, **p < 
0.01. Gene and protein levels were quantified by using the ImageJ software [105]. 
 
3.1.1.5. MRPs gene expression  
Gene expression of MRP1, MRP2, MRP3 and MRP4 hepatocytes treated with 
acetaminophen exhibited no statistical differences at the intensity expression 
after 24 and 72 h of acetaminophen stimulation (Fig. 3.5 C, D & E) with the 
exception of MRP1 at 72 h which was up-regulated (Fig. 3.5 B). Furthermore, 
2D cultures exhibited a higher increase of MRP1 expression than 3D cultures. 
This higher increase could be due to the fact that more cells die in 3D cultures 
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than in 2D cultures. Therefore, more RNA can be collected from the cells that 
have been cultivated in 2D. 
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N = 2 
Figure 3. 5 Gene level expression of MRPs. (A) Semi-quantitative PCR blots of different MRP 
transporter channels after acetaminophen stimulation were compared to their respective control 
in 2D and 3D cultures. The gene expression of (B) MRP1, (C) MRP2, (D) MRP3, and (E) MRP4 
are displayed. Values are expressed as x-fold of control. Gene levels were quantified by using 
the ImageJ software and were normalized to GAPDH; *p ˂ 0.05, **p ˂ 0.01, *** p ˂ 0.001 [105]. 
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3.1.1.6. MRP1 transporter activity 
Hepatocytes were incubated with 4 μM of 5-CFDA for 30 min. 5-CFDA diffuses 
into the cells where it is cleaved by esterases into caboxyfluorescein 
succinimidyl ester (CFSE). In hepatocytes, CFSE is exported into the cell 
culture supernatant by the activity of hepatic transporters [106]. Finally, the 
elution of 5-CFSE was quantified by collecting the supernatants at different time 
points. Figure 3.6 A shows the concentrations of diffused 5-CFDA and 
metabolized into 5-CFSE by hepatic esterases. Interestingly, the amount of 5-
CFDA diffused and metabolized into 5-CFSE by hepatocytes in 3D was 260% 
higher than in hepatocytes cultured in 2D (****p ˂ 0.0001) after 24 h. After 72 h, 
no statistically significant difference was observed between 2D and 3D, even 
though the amount of 5-CFDA diffused and metabolized by hepatocytes into 5-
CFSE was higher in 3D cultures than in 2D cultures. As depicted in Figure 3.6 B, 
2D and 3D cultures reached the peak of the 5-CFSE efflux after 30 min. After 
24 h, the efflux was 350% higher in 3D cultures than in their 2D counterparts. 
However, after 72 h, no efflux was observed in 2D cultures. In 3D cultures, 
MRP1 exhibited a different behavior after 72 h than after 24 h reached the peak 
of 5-CF efflux 20 min after incubation. 
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Figure 3. 6 Comparison of the transport activity of PHH in 2D and 3D cultures. (A) 5-CFDA 
taken up and metabolized into 5-CFSE by human primary hepatocytes in monolayer culture and 
in collagen gel after 24 h and 72 h. Unpaired t test; ****p ˂ 0.0001; (B) 5-CFSE eluted by human 
primary hepatocytes in monolayer culture and in collagen gel through MRP1 after 24 h and 72 h. 
One-way ANOVA; *p ˂ 0.5, ***p ˂ 0.001. Data are expressed as mean ± SD [105]. 
 
3.1.1.7. Metabolism of APA 
The formation rate of the toxic acetaminophen metabolite NAPQI was analyzed 
by LC/MS. However, as NAPQI is a highly unstable compound, it rapidly 
disintegrated into the measuring solution. In the hepatocyte samples, NAPQI 
not only disintegrated but it was also trapped by proteins and other structures, 
such as GSH [107]. However, NAPQI could not be measured by LC/MS. 
Therefore, although not a direct marker, the loss of acetaminophen was used as 
a marker for metabolite formation. A representative study on the kinetic 
metabolic turnover of acetaminophen in 2D and 3D was carried out (Fig. 3.7). 
PHH in culture were incubated with acetaminophen (0.25 mM, 0.5 mM, 1 mM, 5 
mM and 10 mM) for 24, 48 and 72 h. The metabolic turnover of acetaminophen 
at 10 mM was higher in 3D cultures until the end of the incubation. This resulted 
in lower concentrations of acetaminophen remaining in the cultures (51.79 nM 
vs. 73.48 nM after 24 h, 44.84 nM vs. 62.81 nM after 48 h and 39.46 nM vs. 
50.31 nM after 72 h). At the lower concentrations of acetaminophen incubation 
(0.25-5 mM), the remaining acetaminophen concentrations were in the same 
range in 2D and 3D cultures after 48 hours (5 mM) and after 72 h (0.25-1 mM). 
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Next, an independent experiment with 4 donors and incubation with 
acetaminophen for 72 h was performed. Differences between 2D and 3D 
cultures were only detected at high concentrations (10 mM).  
 
 
Figure 3. 7 Remaining acetaminophen after 24, 48 and 72 hours after the incubation with PHH 
in 2D culture compared to 3D culture. The concentrations are expressed as mM acetaminophen 
and were measured by LC/MS [105].  
 
3.1.2. Collagen gel 
3.1.2.1. Optimization of the number of PHH in 3D 
The cell number in collagen gel cultures was optimized by resazurin conversion 
and by optical study of the cell distribution in the μ-slide channel. Due to the 
lack of availability of PHH and due to the similar size with PHH, Huh7 cells were 
used for the optimization of the cell number. 
The highest mitochondrial activity, which was measured by resazurin 
conversion per cell, was observed at a cell density of 5*103 cells per μl of 
collagen gel (Figure 3.8). This cell density seems to ensure an optimal 
exchange of substances in the nutrient medium, as the cells are located in the 
linear range of the reaction. In addition, transmitted light micrographs were 
taken at low magnification (x 40) in order to investigate the cell distribution in 
the µ-slide channel, as at this magnification the total width of the µ-slide channel 
was visible in the micrograph. Cultures below 5*103 cells/μl did not present a 
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homogenous distribution of the cells in the channel, whereas cultures with 
higher numbers of cells form localized aggregations (Figure 3.9). 
 
Figure 3. 8 Resazurin conversion of the collagen gel cultures (A) and per cell (B). Fluorescence 
was measured by plate reader. Data are showed as mean ± SD.  
 
 
Figure 3. 9 Transmitted light micrograph of Huh-7 cells entrapped in collagen gels among the μ-
slide channel with different cell dilutions (x 40 magnification). Scale bar 1000 µm. 
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3.1.2.2. Cell morphology studies 
PHH morphology was investigated by observing the cells under the light 
microscope (Fig. 3.10). PHH that were cultured with the 3D collagen gels 
technique maintained a round shape and formed aggregates, whereas cells in 
2D cultures rapidly gained a planar and fibroblast-like appearance after being 
cultured for several days. In addition, after 14 days of culture, hepatocytes in 2D 
died and detached from the plate. 
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Figure 3. 10 Transmitted light micrograph of PHH on monolayer and entrapped in collagen gels: 
day 1 (A) 2D, (B) 3D; day 7 (C) 2D, (D) 3D; day 14 (E) 2D, (F) 3D; day 21 (G) 2D, (H) 3D; day 
28 (I) 2D, (J) 3D (x 200 magnification). PHH in 2D cultures are indicated by yellow arrows while 
blue arrows are indicated the plate areas left by the detached PHH. PHH aggregates are 
indicated by white arrows. Scale bar 200 µm. 
 
3.1.2.2. Cell Viability 
PHH viability was investigated by live/dead staining (Fig. 3.11). However, in 
collagen gel cultures, it was impossible to perform cell quantification as, in 
collagen gel, cells are entrapped a different levels. Therefore, we measured 
mitochondrial activity by resazurin conversion, which allows for the indirect 
determination of cell viability (Fig 3.12).  
3.1.2.2.1. Live/Dead staining 
In the framework of a live/dead staining of PHH, stained living cells, green 
fluorescence (Calcein-AM, 2µM) and dead cells, red fluorescence (Ethidium 
homodimer, 4 µM). Figure 3.11, showed an increase of the number of dead 
cells in 2D in comparison to 3D cultures over 28 days. 
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Figure 3. 11 Survival of PHH cultured on collagen monolayer and embedded in collagen gels (x 
100 magnification): day 1 (A) 2D, (B) 3D; day 7 (C) 2D, (D) 3D; day 14 (E) 2D, (F) 3D; day 21 
(G) 2D, (H) 3D; day 28 (I) 2D, (J) 3D.  
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3.1.2.3.2. Resazurin conversion 
Mitochondrial activity was assessed by a measurement of the intracellular 
conversion of resazurin to resorufin (Fig. 3.12). A significant statistical 
difference (*p < 0.05) was observed after 21 and 28 days of culture. This 
observation, prove that PHH entrapped in collagen gel maintain higher 
mitochondrial activity during the time of culture. 
        
Figure 3. 12 Mitochondrial activity was assessed by resazurin conversion. Fluorescence was 
normalized to % of day 1 and 2D and 3D cultures were compared. Fluorescence was measured 
by plate reader. Data are expressed as mean ± SD; one-way ANOVA, *p ˂ 0.05 [46]. 
 
3.1.2.4. Glucose production 
Glucose production (glucogenolysis) exhibited a significant statistical difference 
(*p ˂ 0.05, ***p ˂ 0.001) over the 28 days of culture (Fig. 3.13). PHH seem to 
maintain this functional parameter for 28 days with collagen gel but not in 
monolayer culture. 
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Figure 3. 13 Glucose production (glucogenolysis) over 28 days was compared in 2D and 3D 
cultures. Absorbance was measured by plate reader. Data are expressed as mean ± SD; one-
way ANOVA, *p ˂ 0.05, ***p ˂ 0.001 [46]. 
 
3.1.2.5. Ammonia detoxifiation 
Ammonia detoxification capacity exhibited a decrease over 28 days (Fig. 3.14). 
No statistical difference was observed between 2D and 3D cultures. However, 
3D cultures maintained a low detoxification capacity, while the detoxification 
capacity of 2D cultures decreased. 
 
        
Figure 3. 14 De-toxification of ammonia over 28 days was compared in 2D and 3D cultures. 
Absorbance was measured by plate reader. Data are showed as mean ± SD [46]. 
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3.1.2.6. Enzymatic activity of CYP450 
3.1.2.6.1. Gene expression 
CYPs are enzymes which are responsible for the major metabolism processes 
in the liver. Therefore, gene expression was investigated in order to determine 
the differences between 2D and 3D cultures over the time of culture. No 
significant statistical difference in the gene expression of the CYPs was 
observed between 2D and 3D cultures. Representative blots from the different 
CYPs are presented in figure 3.15. 
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Figure 3. 15 Semi-quantitative PCR blots of different CYPs (A-I) were compared to their 
respective control in 2D and 3D cultures for 28 days. Values are expressed as x-fold of control. 
Gene levels were quantified by using the ImageJ software and were normalized to GAPDH; 
one-way ANOVA, *p ˂ 0.05. 
 
3.1.2.6.2. Phase I (CYPs) and phase II enzymatic activity 
3.1.2.6.2.1. Phase I 
Phase I enzymatic activity was investigated by a fluoresce-based assay. At day 
1 (Fig. 3.16 A), only CYP1A1/2 and CYP2D6 showed a significant statistical 
difference (*p ˂ 0.05, **p ˂ 0.001, ***p ˂ 0.0001). During the rest of the time of 
culture, PHH showed a similar pattern maintaining higher activity in 3D cultures 
with the exception of CYP2C8/9. CYP1A1/2, CYP2A6, CYP2C8/9, and CYP2D6 
exhibited significant statistical differences.  
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Figure 3. 16 Phase I activity of CYP 1A1/2, 2A1, 2A6, 2B6, 2C8/9, 2D6, 2E1, 3A4 in PHH. (A) 
Day 1, (B) day 7, (C) day 14, (D) day 21 and (E) day 28 in monolayer and collagen gel. Data 
are showed as mean ± SD; one-way ANOVA, *p ˂ 0.05, **p ˂ 0.001, ***p ˂ 0.0001. 
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3.1.2.6.2.2. Phase II 
Phase II enzymatic activity was studied in the same way as the phase I activity, 
by a fluoresce-based assay. At day 1 (Fig. 3.17 A) and 7 (Fig. 3.17 B), 2D 
cultures exhibited higher enzymatic activity than 3D cultures. Significant 
statistical differences were observed in GSH and CHC. After 14 days of culture 
(Fig. 3.17 C), the enzymatic activity in 2D and 3D cultures became similar and 
the tide turned. GSH and HC exhibited significant statistical differences. At day 
21 (Fig. 3.17 D) and 28 (Fig. 3.17 E), 3D cultures maintained higher enzymatic 
activity than 2D cultures. Significant statistical differences were observed in 
GSH and HC at day 28. 
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Figure 3. 17 Phase II activity of different conjugation reactions of resorufin (Res), glutathione 
(GSH), uridine (UGT), 7-hydroxy coumarin (HC), 7-hydroxy-4(trifluoromethyl) coumarin (HFC), 
fluorescein (FL), 3-(2-(N,N-diethylamino)ethyl)-7-hydroxy-4-methyl-coumarin (AHMC), and 3-
cyano-7-hydroxycoumarin (CHC). (A) Day 1, (B) day 7, (C) day 14, (D) day 21, and (E) day 28 
in PHH in monolayer and collagen gel. Data are expressed as mean ± SD; one-way ANOVA, *p 
˂ 0.05, **p ˂ 0.001, ***p ˂ 0.0001. 
 
3.1.2.7. Efflux assays 
3.1.2.7.1. Transporter channel gene expression 
Transporter channels are proteins which are located at the apical and at the 
basolateral membranes and which are responsible for the major transporter 
processes in hepatocytes. Therefore, gene expression was investigated in order 
to determine differences between 2D cultures and 3D cultures during the time of 
culture. With the exception of OCT1 and MRP6 in monolayer cultures at day 28, 
no differences in the gene expression of the transporter channels were 
observed between 2D and 3D cultures. Representative blots from the different 
transporters are shown in figure 3.18. 
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Figure 3. 18 Semi-quantitative PCR blots of different hepatic transporter channels (A-M) were 
compared to their respective control in 2D and 3D cultures for 28 days. Gene expressions were 
detected by semi-quantitative PCR. Values are expressed as x-fold of control. Gene levels were 
quantified by using the ImageJ software and were normalized to GAPDH. One-way ANOVA; *p 
˂ 0.05. 
 
3.1.2.7.2. Transporter activity 
3.1.2.7.2.1. Multidrug-resistant associated protein - 1 (MRP1) 
Figure 3.19 A presents the concentrations of diffused 5-CFDA and metabolized 
into 5-CFSE by hepatic esterases. 2D and 3D cultures presented a decrease of 
the uptake of 5-CFDA over day 21. Significant statistical differences (***p ˂ 
0.0001) were observed at days 1, 7, and 14. Then, at day 28, it was possible to 
observe a slight increase of the uptake of 5-CFDA. Figure 3.19 B-F depict the 
elution of 5-CFSE in 2D and 3D cultures. 2D cultures presented elution only at 
day 1 and 14. However, 3D cultures maintained the transporter activity over 28 
days, although it decreased during the time of culture. Significant statistical 
differences were observed between 2D and 3D cultures over the 28 days of 
culture (*p ˂ 0.05, **p ˂ 0.001, ***p ˂ 0.0001). 
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Figure 3. 19 Substrate/product efflux on MRP1 in PHH at (A) day 1, (B) day 7, (C) day 14, (D) 
day 21 and (E) day 28 in 2D and 3D cultures. Data are showed as mean ± SD. One-way 
ANOVA; *p ˂ 0.05, **p ˂ 0.001, ***p ˂ 0.0001. 
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3.1.2.7.2.2. Multidrug-resistant protein 1/P-glycoprotein (MDR1/P-gp) 
An elution assay was used to investigate Rhodamine 123. Hepatocytes were 
incubated for 30 min with 3 μM of Rhodamine 123, so that it diffuses into the 
cells. In hepatocytes, Rhodamine 123 is exported into the cell culture 
supernatant by the activity of MDR1/P-gp hepatic transporters. Finally, the 
elution of Rhodamine 123 was quantified by collecting the supernatants at 
different time points. Figure 3.20 A exhibits the concentrations of diffused 
Rhodamine 123 into the PHH. In 2D cultures, a decrease of the diffused 
Rhodamine 123 was recorded over 28 days. However, in 3D cultures, the 
diffused Rhodamine 123 reached a peak at day 14. Significant statistical 
differences (***p ˂ 0.0001) were observed at day 1, 14 and 21. Figure 3.20 B-F 
depict the elution of Rhodamine 123 in 2D and 3D cultures. Both cultures 
exhibited a similar tendency to increase the amount of Rhodamine 123 which is 
eluted during the incubation time. However, 2D cultures showed an elution of 
Rhodamine 123 only at day 1 and 7; whereas 3D cultures maintained their 
transporter activity over 28 days, although it decreased during the time of 
culture. Significant statistical differences were observed (*p ˂ 0.05, **p ˂ 0.001, 
***p ˂ 0.0001). 
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Figure 3. 20 Substrate/product efflux on MDR1/P-gp in PHH at (A) day 1, (B) day 7, (C) day 14, 
(D) day 21 and (E) day 28 in 2D and 3D cultures. Data are expressed as mean ± SD. One-way 
ANOVA; *p ˂ 0.05, **p ˂ 0.001, ***p ˂ 0.0001. 
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3.1.2.8. Drug toxicity 
Drug toxicity tests were performed by incubating PHH with different 
concentrations of acetaminophen and diclofenac. Then, cell viability was 
measured indirectly by resazurin conversion which measures the mitochondrial 
activity of the PHH.  
3.1.2.8.1. Acetaminophen 
At day 1 (Fig. 3.21 A), 3D cultures showed a more defined toxicity curve than 
2D cultures. 2D cultures showed no variations in the drug concentration in 
mitochondrial activity at days 7 (Fig. 3.21 B) and 14 (Fig. 3.21 C); whereas 3D 
cultures maintained dose-response variations in mitochondrial activity. 
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Figure 3. 21 Acetaminophen toxicity in PHH at (A) day 1, (B) day 7, (C) day 14, (D) day 21 and 
(E) day 28 in 2D and 3D cultures. Data are showed as mean ± SD. 
 
3.1.2.8.2. Diclofenac 
At day 1 (Fig. 3.22 A), 3D cultures showed a more defined toxicity curve than 
2D cultures. 2D cultures showed no variations in drug concentration in 
mitochondrial activity at days 7 (Fig. 3.22 B) and 14 (Fig. 3.22 C); whereas 3D 
cultures maintained dose-response variations in mitochondrial activity. 
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Figure 3. 22 Diclofenac toxicity in PHH at (A) day 1, (B) day 7, (C) day 14, (D) day 21 and (E) 
day 28 in 2D and 3D cultures. Data are expressed as mean ± SD. 
 
3.2. Flow cultures 
3.2.1. Perfusion assays 
Collagen gel, 3D-Life hydrogel and hydrogel were loaded into µ-slide channels. 
Perfusion assays were performed in order to determine the adequate flow rate 
for the microfluidic system. Resazurin sodium salt (25%) was diluted in DPBS 
and used as a perfusion solution due to its dark blue color which allows for the 
study of the perfusion solution behavior at different flow rates (Fig. 3.23). In 
collagen gels, a homogeneous flow was observed only at low flow rates (Fig. 
3.23 A). Moreover, collagen gel containing re-suspended cells showed no 
alteration of the flow rate (Fig. 3.23 C). 
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Figure 3. 23 Sequence of micrographs showing the perfusion flow through the µ-slide channels 
at different speeds (x40). (A) Collagen gel, 100 µl/h; (B) Collagen gel, 2 ml/h; (C) Collagen gel 
with Huh7, 100 µl/h; (D) 3D-Life hydrogel, 100 µl/h; (E) Poly(ethylene glycol) hydrogel with Huh7, 
100 µl/h; (F) Poly(ethylene glycol) hydrogel with Huh7 2 ml/h. (G) Diffusion rate in collagen gels 
at 100 µl/h flow. Data are expressed as mean ± SD. 
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3.2.2. Flow in the microfluidic system 
The continuous flow of 4 channels simultaneously was achieved by creating an 
individual medium reservoir for each channel. The syringe pump was used to 
pump air into the medium reservoir containers in order to increase the pressure 
slightly inside the falcon tubes, favoring the release of the medium (Fig. 2.12). 
Eluted medium from the different channels was collected in falcon tubes during 
24 h. Flow rate ranged between of 80 to 100 µl/h in the four channels of the µ-
slide (Fig. 3.24). 
 
Figure 3. 24 Representation of the flow in the different channels of the µ-slide. 
 
3.2.3. Cell morphology studies 
PHH morphology was investigated by the observation of the cells under the 
microscope (Fig. 3.25). PHH maintained a round shape and formed aggregates 
which lasted over the time of culture. In static cultures, PHH were seeded in 96-
well plates, whereas in flow cultures, PHH were seeded in µ-slides. As the area 
of the µ-slide channels is twice the area of the 96-well plates, the micrographs 
below present a higher concentration of cell aggregates in static than in flow 
cultures. 
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Figure 3. 25 Transmitted light micrograph of PHH entrapped in collagen gels in static and flow 
culture: day 1 (A) static, (B) flow; day 7 (C) static, (D) flow. (x 200 magnification). PHH 
aggregates are indicated by white arrows. Scale bar 200 µm. 
 
3.2.4. Cell viability 
PHH viability was investigated by live/dead staining (Fig. 3.26). However, in 
collagen gel cultures, cell quantification could not be performed as cells are 
entrapped in different levels in collagen gel. Therefore, we measured 
mitochondrial activity by resazurin conversion which allows for an indirect 
determination of cell viability (Fig. 3.27). 
3.2.4.1. Live/Dead staining 
In the framework of a live/dead staining of PHH, stained living cells, green 
fluorescence (Calcein-AM, 2µM) and dead cells, red fluorescence (Ethidium 
homodimer, 4 µM). Figure 3.26 shows a slightly increase of the number of dead 
cells in flow cultures compared to static cultures over 7 days. 
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Figure 3. 26 Survival of PHH embedded into collagen gel cultured in static and flow condition (x 
100 magnification): day 1 (A) 3D static, (B) 3D flow; day 7 (C) 3D static, (D) 3D flow.  
 
3.2.4.2. Resazurin conversion 
Mitochondrial activity was assessed by measuring the intracellular conversion of 
resazurin to resorufin. No significant statistical differences were observed after 
7 days of culture. However, in static cultures, PHH maintained a higher 
mitochondrial activity during the time of culture. 
        
Figure 3. 27 Mitochondrial activity was assessed by resazurin conversion. Fluorescence was 
measured by plate reader. Data are expressed as mean ± SD. 
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3.2.5. Glucose production 
Glucose production (glucogenolysis) exhibited significant statistical differences 
(*p ˂ 0.05) over the 7 days of culture (Fig. 3.28). PHH seems to maintain this 
functional parameter for 7 days in static culture, but not in flow culture. 
 
        
Figure 3. 28 Glucose production (glucogenolysis) in 3D static and flow cultures over 7 days. 
Absorbance was measured by plate reader. Data are showed as mean ± SD. One-way ANOVA; 
*p ˂ 0.05. 
 
3.2.6. Enzymatic activity of CYP2E1 and CYP3A4 
Enzymatic activity of CYP2E1 and CYP3A4 were investigated by stimulating the 
PHH with acetaminophen (100 µM) (Fig. 3.29) and diclofenac (10 µM) (Fig. 
3.30). Supernatants were collected at different time points and measured by 
LC/MS.  
3.2.6.1. Metabolism of acetaminophen  
Enzymatic activity of CYP2E1 was investigated indirectly by measuring the 
amount of APA-sulphate which is metabolized by PHH. No significant statistical 
differences were observed. APA concentration exhibited a similar decreasing 
tendency in static and flow cultures from day 1 to day 7 (Fig. 3.28 A-B). 
However, the APA-sulphate area exhibited a slight increase which correlates 
with the incubation time in static and flow cultures at day 1, but not at day 7 (Fig. 
3.28 C-D). 
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Figure 3. 29 Activity of the CYP2E1 during the metabolism of acetaminophen. (A-B) Remaining 
APA in supernatants after an incubation time of 120 min. (C-D) Metabolized APA-sulphate by 
PHH. Data are showed as mean ± SD. 
 
3.2.6.2. Metabolism of diclofenac  
The enzymatic activity of CYP3A4 was investigated indirectly by measuring the 
amount of 4-Hydroxydiclofenac which was metabolized by PHH. No significant 
statistical differences were observed. The concentration of diclofenac showed a 
similar decreasing tendency in static and flow cultures at days 1 and 7 when the 
incubation time increased (Fig. 3.29 A-B). However, 4-Hydroxydiclofenac area 
showed a slight increase which correlates with the incubation time in static and 
flow cultures at day 1 and 7 (Fig. 3.29 C-D). 
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Figure 3. 30 Activity of the CYP2C9 during the metabolism of diclofenac. (A-B) Remaining 
diclofenac in supernatants after an incubation time of 120 min. (C-D) Metabolized 4-
hydroxydiclofenac by PHH. Data are expressed as mean ± SD. 
 
3.2.7. Drug toxicity 
Drug toxicity tests were performed by incubating PHH with different 
concentrations of acetaminophen and diclofenac. Then, cell viability was 
measured indirectly by resazurin conversion which measures the mitochondrial 
activity of the PHH.  
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3.2.7.1. Acetaminophen 
At day 1 (Fig. 3.31 A), 3D cultures showed a more defined toxicity curve than at 
day 7 in both cultures. In addition, flow cultures exhibited no drug-response the 
in mitochondrial activity at day 7 (Fig. 3.31 B); whereas static cultures 
maintained dose-response variations in mitochondrial activity. 
 
 
 
Figure 3. 31 Acetaminophen toxicity in PHH at (A) day 1, (B) day 7 in static and flow cultures. 
Data are showed as mean ± SD. 
 
3.2.7.2. Diclofenac 
At day 1 (Fig. 3.32 A), 3D cultures showed a more defined toxicity curve than at 
day 7 in both cultures. In addition, flow cultures exhibited no drug-response the 
in mitochondrial activity at day 7 (Fig. 3.32 B); whereas static cultures 
maintained dose-response variations in mitochondrial activity. 
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Figure 3. 32 Diclofenac toxicity in PHH at (A) day 1, (B) day 7 in static and flow cultures. Data 
are showed as mean ± SD. 
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4. Discussion 
The liver is the organ which is primarily responsible for the first defense of the 
body against toxins and harmful substances [4, 108]. Furthermore, the liver 
regulates the metabolism of the body, and is responsible for glycogen storage, 
bile production, and plasma protein synthesis [1, 14]. Therefore, during the 
development of new drugs, specific toxicity tests analyse the new medicine’s 
potential for causing liver injury. It has been proven that liver injury is the most 
common cause for withdrawing medicaments from the market [5]. Traditional 
toxicity tests, like those being performed by pharmacological companies, use 
laboratory animals with the intention of avoiding potential damage to humans. 
However, animal testing is controversial as, on the one hand, it raises ethical 
questions on the right to use animals, and, on the other hand, the translation of 
the results that have been obtained in animals to the human situation has 
proven to be difficult. In addition, since the approval of the Directive for the 
Protection of Vertebrate Animals used for Experimental and other Scientific 
Purposes (86/609/EEC) in 1986, the needs for laboratory animal care have 
increased, which, in turn, has led to higher animal maintenance costs for the 
pharmaceutical companies [8]. Thus, ECVAM is working on the validation of 
methods to assess testing safety, and drug efficiency, which reduce or replace 
the use of laboratory animals. Some of these methods use cells, like e.g. 
hepatoma cell lines, hepatocytes-like cells and PHH.  
PHH present two main problems; the first one is the limited access to human 
liver tissue and the second one is their short life span [109], which refers to the 
rapidly loss of their phenotype and consequently loss of polarity in traditional 
cultures. Then, PHH spread on the culture plates generating an epithelial-
mesenchymal transition during which the hepatocytes lose many liver specific 
functions, and decrease cell viability during the time of culture [31, 32]. 
Hepatocytes are very specialized cells and present an atypical polarization, 
apical and basolateral membranes, which is necessary to be functional [17]. 
ECM is crucial to keep the differentiated state of hepatocytes [110]. Thus, in 
order to maintain hepatocytic phenotype during the time of culture, PHH have 
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been cultured in different matrices which incorporate ECM proteins. The most 
common method used for long-term cultures is the culture of PHH sandwich 
conformation, being collagen and Matrigel® the most used materials [30]. 
Sandwich culture allows the hepatocytes to maintain their phenotype and 
consequently liver specific functions [53, 111, 112]. Nonetheless, in vitro culture 
of hepatocytes differs from the in vivo situation. In traditional 2D and 3D cultures, 
the medium is loaded over the cells; however, in vivo liver tissue presents a 
double blood supply, 75%-80% deoxygenated blood from the portal vein and 
25%-20% oxygenated blood from the portal artery [113]. As a result, bioreactors 
which are 3D cultures with a continuous flow have been developed (Table 1.3). 
Many of these devices try to mimic the organotypic conditions of the liver which 
enable a more realistic study of the cell-cell and cell-environment interactions 
[82]. Nonetheless, the high cost of the equipment and the low throughput 
reduce their use in hepatotoxicity studies. 
Due to the low PHH availability, hepatoma cell lines are used as an alternative 
in toxicity assays. Contrary to PHH, they proliferate indefinitely, and therefore 
provide an appropriate supply of cells. However, the low activity of metabolic 
enzymes in hepatoma cell lines in comparison to PHH, and the variations 
between the different passages restrict their use in drug testing [24, 114]. In 
recent years, another alternative for toxicity studies and possible future source 
for cell transplantation has been studied, which focuses on the generation of 
hepatocyte-like cells from extrahepatic cell sources. For instance, 
programmable cells of monocyte origin (PCMO) have been differentiated into 
hepatocyte-like cells with their corresponding characterization in order to be 
used in cell therapies and toxicological testing [104, 115-118]. Another extra-
hepatic cell source for hepatic-like cells is the adipose-derived mesenchymal 
cells (Ad-MSCs) [119, 120]. However, low expression of hepatocytic markers, 
low metabolizing capacity, and difficulties of generating large reproducible 
hepatocyte-like cells, still limit their use in drug testing. Despite their limitations, 
PHH are still the “gold standard” for drug metabolism and toxicity studies [30, 
39].  
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4.1. Choice of the matrix 
Several bioreactors and microfluidic systems for PHH culture, which have 
already been commercialized or exist as prototypes, dispose of cavities or 
spaces which prevent the cells from the direct contact with the flow of the 
medium, so that they are protected against shear stress, and permit the 3D 
disposition of the cells. Two examples of this type of bioreactors are the hollow 
fiber bioreactor [76] and the KitChip bioreactor [79]. The µ-slide, for this part, 
presents 6 channels in which the cells are seeded and which are in direct 
contact with the flow of the medium. However, one characteristic of the µ-slide 
is the possibility of using different matrices which allow the study of several liver 
diseases as liver ECM composition changes at different stages of the disease, 
like e.g., fibrosis and cirrhosis [4]. A first sight, solid matrices, which are also 
called ‘scaffolds’, may present the best option, as they have pores which do not 
disturb the flow of the medium and permit the three-dimensional culture of cells 
[67]. However, scaffolds were discarded in this project, because they could not 
be introduced in the channels. Therefore, different hydrogels were tested.  
Due their reproducibility and the possibility of mimicking the ECM, two synthetic 
hydrogels, 3D-Life Hydrogels and poly(ethylene glycol) hydrogels, were tested 
[48]. Both hydrogels did not exhibit a homogenous flow. Contrary to scaffolds, 
hydrogels are water-swollen polymers [43] and under a continuous flow, 
hydrogels experience a volume change which leads to a reduction of their pore 
sizes [121] In addition, 3D-Life hydrogels have a small pore size (8 nm), which 
renders the flow difficult [92]. Because of these facts, the pressure on the gel 
increased during the flow time, which resulted in the damage of the gel structure, 
which, in turn, would explain the heterogeneous flow. 
Finally, collagen a natural hydrogel and the most common ECM protein in 
mammals was tested as well [52]. Collagen is highly compatible and non-toxic 
to the PHH [48]. Interestingly, collagen gel exhibited a homogeneous flow 
through the µ-slide channel. Contrary to synthetic hydrogels that have a small 
pore size, collagen gel with a concentration of 2 mg/ml have a pore size 
between 1.2-1.8 µm [122] which allow homogeneous flow through the hydrogel. 
In addition, the collagen gel containing cells did not exhibit any alteration of the 
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flow at low speed (100 µl/h). Therefore, collagen gel was chosen as our matrix 
for the culture of PHH under continuous flow. 
4.2. Collagen sandwich cultures better than monolayer cultures  
Previous studies have demonstrated that PHH in collagen sandwich preserve 
hepatocytic functions and delay dedifferentiation during the time of culture [30, 
53, 54, 111, 123]. Therefore, we have investigated the possibility of testing 
hepatotoxicity in sandwich cultures instead of the monolayer cultures that are 
currently used in the pharmaceutical industry, by using acetaminophen as a 
model drug. Acetaminophen is a drug which is used all over the world. It is safe 
at therapeutic doses [2, 89], but an over dosage can lead to acute liver failure 
[3]. In vitro monolayer cultures do not exhibit symptoms of toxicity at lower 
concentrations (0.5-1 mM) while in vivo, lower concentrations cause liver 
necrosis [124, 125]. Firstly, our findings corroborate that PHH in 2D cultures 
change their morphology, die and detach, while PHH in 3D cultures keep their 
structure over the time of culture. Then, PHH that had been stimulated with 
acetaminophen over 72 h and different aspects were studied. The exposure to 
acetaminophen resulted in an increase of cell death in 3D but not in 2D cultures. 
Similar results had been obtained in previous studies, in which rat hepatocytes 
cultured on a polystyrene scaffold had been incubated with acetaminophen [74].  
In hepatocytes, acetaminophen is metabolized by the enzyme CYP2E1 during 
the phase I of the metabolism. During the metabolism, the highly toxic product 
N-acetyl-p-benzoquinone imine (NAPQI) is formed [126, 127]. During the 
treatment with acetaminophen, the level of the CYP2E1 protein increases in 3D 
but not in 2D cultures. Therefore, higher concentrations of NAPQI, which 
accumulates in the cells and induces cell necrosis, have been registered [128, 
129]. On the other hand, SOD1, an antioxidant protein that protects PHH from 
oxidative stress [130] decreases after the stimulation with acetaminophen in 3D 
but not in 2D cultures. This decrease indicates a nitration of SOD1 by reactive 
nitrogen species which leads to an increment of toxicity in the mitochondria 
through the reaction of nitric oxide with the superoxide [131]. In addition, the 
kinetic metabolic turnover of acetaminophen was higher in 3D than in 2D 
cultures.  
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Moreover, the hepatic transporters, MRP1, MRP2, MRP3 and MRP4, have 
been studied at gene level after the stimulation with acetaminophen. Only the 
expression of MRP1 was up-regulated after the incubation with acetaminophen. 
Therefore, the transport activity of MRP1 was investigated in more detail: MRP1 
is a transport protein located at the basolateral membrane and belongs to the 
ABC transporter family [132, 133]. At gene level, no statistical difference has 
been observed between 2D and 3D cultures. However, 3D cultures presented 
higher import and efflux activity than the 2D cultures. These findings indicate 
that the transporter activity is influenced by the culture conditions: In 2D cultures, 
basolateral and apical transporters are located on the cell surface which leads 
to a decrease of the transporter activity [134]. Another possible reason for the 
reduction of the transporter activity is the migration of the protein transporter 
from the surface of the membranes to internal sites under adverse conditions 
[135]. Moreover, the transport activity can be affected by the decrease of the 
substrate specificities due to the switch of the efflux activity between different 
transporter protein isoforms or due to the location of different transporters at 
different membranes when the PHH lose their polarity [136, 137].  
Although it has been proven that sandwich cultures generate results which 
allow for their better comparability to the in vivo situation [30, 53, 54, 123], the 
lack of liver tissue requires a further reduction of the cell number for future 
hepatotoxicity prediction in vitro. Sandwich cultures cannot be performed in 96-
well plates, as the minimal area which is necessary for sandwich cultures, 
corresponds to that of a 24-well plate. However, cultures in 24-well plates 
require a higher number of cells and reduce the throughput compared to 96-well 
plates. An alternative culture model to sandwich cultures is the 3D spheroid 
culture called hepatosphere. Hepatospheres are small aggregates of 
hepatocytes which their organization mimics the in vivo situation and maintain 
hepatocytic phenotype and liver specific functions for 2 weeks [138]. These 
spheroids can be cultured in small culture plates under static conditions but they 
are not suitable for our flow system as the hepatospheres will be flushed away 
from the µ-slide channel by the flow. Therefore, a new culture model which 
enables hepatocytes cultures in 96-well plates and in the ibidi
®
 µ-slide is 
needed.  
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4.3. Culture of PHH in collagen gel 
One of the restrictions of using PHH is the limited access to human liver tissue. 
Therefore, down scaling is necessary in order to improve the efficient use of the 
cells. For this reason, PHH were re-suspended in collagen gels, as they allow 
3D culturing of cells in 96-well plates and in the ibidi® µ-slide. Our results have 
shown that the best possible viability was reached at a cell density of 5*103 cells 
per microliter of collagen. This cell density seems to guarantee an optimal flow 
of substances in the culture medium. In the line with our findings, previous 
studies have proven that hepatocytes that are re-suspended in collagen gels 
with cell densities ranging from 1.5*106 cells/ml to 5*106 cells/ml do not alter the 
laminar flow, while higher cell densities (> 7*106 cells/ml) do not enable any 
laminar flow at all [139]. In addition, PHH entrapped in 3D maintained a round 
shape and formed aggregates which is closer to the in vivo environment 
compared to PHH in 2D cultures [140].  
The characterization of the PHH that had been re-suspended in collagen gels 
was carried out by measuring cell viability, hepatic specific functions and 
hepatotoxicity to drugs and by comparing these results to PHH cultured on 
collagen monolayer in order to determine any improvement due to the culture 
conditions. Our results exhibited that PHH entrapped in collagen gels maintain 
higher viability, glucose, and urea production over the time of culture than 2D 
cultures, which correlates with previous studies carried out with hepatocytes 
cultured in collagen sandwich and collagen entrapped gel cultures [53, 141, 
142]. 
Next, the CYPs were investigated at gene expression level. Previous studies 
had shown that the gene expression of CYPs decreases over time in PHH 
cultured on collagen monolayer [24, 112]. However, our results demonstrated 
that the gene expression of the CYPs tested (CYP1A1, CYP1A2, CYP2A6, 
CYP2B6, CYP2C8, CYP2C9, CYP2D6, CYP2E1 and CYP3A4) was preserved, 
even though they exhibited a decreasing tendency over the time of culture in 
both cultures. However, there is a not strong correlation between gene 
expression and activity [143, 144]. Therefore, we investigated the CYP activity 
by a fluorescence-based assays [103]. CYP activity exhibited a decrease over 
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the time of culture where PHH in 3D cultures maintained higher enzymatic 
activity than 2D cultures with the exception of CYP2C8/9. A possible 
explanation to this fact is that the fluorometric substrate DBF, which was used 
to measure CYP2C8/9 activity, is not very selective. Thus, DBF can be 
metabolized by several CYPs generating larger amount of its metabolite [145]. 
In addition, we studied the enzymatic activity of the phase II between in both 
types of cultures. Contrary to the CYP activities, 2D cultures exhibited a higher 
activity than 3D cultures at day 1 and 7. However, after 14 days of culture, the 
tide turned and the enzymatic activity became higher in 3D cultures than in 2D 
cultures. These results showed that, in 2D cultures, PHH lose their polarized 
state faster, while 3D cultures slow down the depolarization of the cells, thereby 
maintaining enzymatic activity over a longer period of time [14, 30, 123]. Special 
mention needed GSH activity which increased its activity in 3D cultures during 
the first 14 days of cultures and then decreases over time of culture. This fact 
can be explain by the supplementation of the culture medium with amino acids, 
especially with L-proline which induces the GSH activity in 3D cultures [142]. 
PHH are very specialized cells and therefore, they have to be polarized in order 
to be functional [15]. In contrast to other epithelial cells, which dispose of only 
one apical membrane, hepatocytes present several apical and basolateral 
membranes [17]. These membranes are present in polarized PHH and are 
necessary for the uptake and elimination of the metabolite products through the 
sinusoids or through the bile canaliculi [15]. Therefore, different transporter 
channels, like e.g., NTCP, OCT1, MDR1, MDR2, MDR3, MRP1, MRP2, MRP3, 
MRP4, MRP5, MRP6, BSEP, and BCRP, that are located at both membranes of 
the PHH, were studied. Like CYP gene expression, the majority of the 
transporter genes exhibited a decreasing tendency over the time of culture. The 
only exceptions were NTCP, MDR1, MRP1, MRP5, and BCRP, which did not 
follow any pattern. As no statistical differences were observed, the transport 
activity of MRP1 and MDR1/P-gp, which are located at the basolateral and the 
apical membranes respectively, were studied. MRP1 and MDR1/P-gp are 
transport proteins which belong to the ABC transporter family [132, 133]. The 
explanation for the fact that transporter activity was observed in 3D but not in 
2D cultures was given in the section 4.2. 
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Finally, hepatotoxicity was studied by stimulating the PHH in 2D and 3D 
cultures with acetaminophen and diclofenac, which were used as model drugs, 
over 72 h. 3D cultures showed a more defined dose-response toxicity curve 
than monolayer cultures over 14 days of culture. Like acetaminophen, 
diclofenac metabolites are more toxic than the non-metabolized drug. The 
metabolism of diclofenac by CYP 2C9 favors the formation of 4’-
hydroxydiclofenac and 5-hydroxydiclofenac which bind to hepatic proteins 
producing mitochondrial toxicity and consequently cell death [146]. A possible 
reason for this finding is that, in monolayer cultures, PHH are exposed to a 
higher alteration of the environment, which increases cell stress, hepatic 
dedifferentiation, and consequent cell death. The explanation for the fact that 
PHH exhibited higher toxicity after stimulation with acetaminophen was given in 
the section 4.2.  
4.4. Microfluidic system  
In this study we have shown that PHH cultured in 3D preserved their 
hepatocytic functions for a longer time than those in 2D. However, hepatocytes 
are constantly irrigated by blood in the in vivo situation. Culturing PHH under a 
continuous flow mimics the organotypic environment of the liver, which 
improves the detoxification activity of the cells [77]. The first flow cultures were 
performed in bioreactors but the high demand of cells limited their uses [51, 76]. 
As an alternative, microfluidic systems were developed, which enable a 
reduction of the number of cells and an increase of the throughput. Currently, 
there are several publications regarding microfluidic systems for the culture of 
PHH. Some of them are commercialized, like e.g. Quasi-Vivo® [77] and 
LiverChip [78], but the majority exists only as prototypes, like e.g. KITChip [147], 
HepaChip® [80], and Microfluidic Array [148]. However, all of them are 
composed by specific platforms, chips or arrays which have been made for their 
respective systems. In addition, those systems include expensive and 
sophisticated devices which pump the medium and oxygen into the systems 
restricting their use in hepatotoxicity prediction [77, 78, 80, 147, 148]. As we 
have already demonstrated, PHH maintain their liver functions when they are 
cultured in 3D. Therefore, we hypothesized that if we can apply a continuous 
flow to our 3D cultures we will improve the hepatocytic functions over the time 
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of culture. The microfluidic system that we present does not require expensive 
devices, like e.g. standard syringe pump, µ-slide, falcon tubes and tubing 
(Section 2.2.6.2). The choice of the matrix and the optimization of the flow rate 
were discussed in previous section (Section 4.1). 
The characterization of the PHH was carried out by measurement cell viability, 
hepatic specific functions and hepatotoxicity to drugs and compared to PHH 
culture in static conditions in order to determine any improvement due to the 
culture conditions. Our data demonstrated to be contradictory, for instance, 
live/dead staining exhibited that PHH survive in the microfluidic system, 
nevertheless, a standard method used to measure cell viability by quantifying 
the mitochondrial activity of the cells (resazurin conversion) did not show any 
resorufin conversion. Similar results were found during the metabolism of 
acetaminophen and diclofenac which correlates to the activity of CYP2E1 and 
CYP2C9 respectively in static and flow cultures. On the other hand, glucose 
production and hepatotoxicity dose-response was only maintained in static 
cultures. As our system does not have any extra oxygen supply, a possible 
reason for the no metabolization of resazurin, no glucose production, and no 
hepatotoxicity dose-response is that PHH embedded in collagen gels and 
loaded into the µ-slide channel do not receive enough oxygen supply producing 
cell death by hypoxia. Also, big molecules in the medium such as glucose 
hinder the oxygen transport [149]. Another reason could be explained by the 
low mass transport of the hydrogels. Under a continuous flow, hydrogels 
experience a volume change which leads to a reduction of their pore sizes 
increasing the shear stress on the cells and consequently causing cell damage 
[121].  
In order to further improve the characterization of the PHH in the µ-slide system, 
new approaches have to be committed. For instance, alternative experiments 
have to be performed or an improvement of the methods here performed has to 
be accomplished so that measurements can be performed directly on the µ-
slide. The µ-slide system introduced in this study involves two major problems: 
One difficulty is the low throughput compared to traditional cultures in 96-well 
plates, which is nevertheless still higher than in some of the microfluidic 
systems. The other difficulty is the flow rate differences between the µ-slide 
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channels, which could be solved through the use of a peristaltic pump with a 
very low flow rate (> 100 µl/h) that creates an independent flow for each µ-slide 
channel. In future studies, the extensive characterization of the µ-slide system 
has to be broadened in order to benefit from the standardization of the system 
in every laboratory.  
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5. Abstract 
Traditional toxicity tests are characterized by the use of in vitro and in vivo 
laboratory animals with the purpose of avoiding potential damage to humans. 
The use of animals for drug testing raises ethical questions, and involves high 
costs as well as a lack of reliability. However, the use of PHH as an alternative 
to animal testing involves two main problems: the limited access to liver tissue 
and the short life span of these cells. Therefore, hepatoma cell lines and 
hepatocyte-like cells from extra hepatic cell sources have been investigated as 
an alternative in toxicity assays, but their low expression of hepatocytic markers 
and their low metabolization capacity limit their use in drug testing. Polarization 
plays a key role in drug metabolism. Therefore, the hepatotoxicity in 2D and 3D 
(sandwich) cultures has been investigated here by using acetaminophen as a 
model drug. Our data have demonstrated that cell death is higher in 3D cultures 
than in 2D cultures as there is a higher metabolism of acetaminophen and 
therefore higher concentration of toxic metabolites (NAPQI) formed after 
treatment with acetaminophen. During these experiments, it has been observed 
that the protein expression of CYP2E1 and SOD1 depends on the concentration 
of acetaminophen. Therefore, the increase of the concentration of 
acetaminophen has led to a parallel increase of the expression of CYP2E1, but 
to a decrease of the expression of SOD1 in 3D, but not in 2D cultures. In 
addition, higher import/export rates have been observed for the multidrug 
resistance-associated protein-1 (MRP1), which is a specific transporter protein 
for acetaminophen metabolite transport in 3D cultures. 3D cultures exhibited 
better comparability of the results to the in vivo situation. 
However, the limited access to liver tissue and the impossibility of using 
sandwich culture in small culture plates restrict the use of sandwich cultures for 
high-throughput screening. Therefore, PHH have been re-suspended in 
collagen gels. In this 3D model, cell viability, glucose production, and NH4 
detoxification have been preserved at a higher level over 28 days than in 2D 
cultures. Similar results have been observed during the measurements of the 
phase I and II metabolic activity. Furthermore, PHH have exhibited higher 
import/export rates in two transporter proteins, MRP1 and multidrug resistance 
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protein-1 (MDR1/P-gp), located at the basolateral and apical membrane 
respectively. Finally, PHH have exhibited higher toxicity in 3D than in 2D 
cultures after being stimulated by acetaminophen and diclofenac. 
The culture of PHH under a continuous flow has demonstrated an improvement 
of the detoxifying activity of the cells. However, microfluidic systems are 
expensive and sophisticated devices whose use is restricted in hepatotoxicity 
prediction. Therefore, a simple and cheap microfluidic system has been tested 
in this work. The data from the live/dead staining has proven the survival of 
PHH in the microfluidic system. Similar results have been found during the 
metabolism of acetaminophen and diclofenac which correlates with the activity 
of CYP2E1 and CYP2C9 respectively in static and flow cultures. However, 
these findings could not be corroborated by the use of fluorescence and 
absorbance assays measured by a plate reader. In order to improve the 
characterization of the PHH in the µ-slide system, new approaches have to be 
developed, along with alternative experiments and an improvement of methods. 
In this thesis, the behaviour of PHH on natural collagen gels in different culture 
conditions has been studied. However, the liver ECM is not only composed of 
collagen, but also contains proteins and proteoglycans. In addition, non-
parenchymal cells are involved in the inflammatory response. Therefore, future 
studies should focus on testing hepatotoxicity in co-cultures of PHH and non-
parenchymal cells in microfluidic systems with a matrix comprising several ECM 
proteins in order to achieve in vitro results which are highly comparable to the in 
vivo situation. 
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7. Zusammenfassung 
In traditionellen Toxizitätstests werden in vitro und in vivo Versuchstiere 
verwendet. Auf diese Weise sollen mögliche Schäden am Menschen verhindert 
werden. Die Verwendung von Versuchstieren zur Medikamentenprüfung wirft 
jedoch ethische Fragen auf und ist darüber hinaus mit hohen Kosten und einem 
Mangel an Reliabilität verbunden. Die Verwendung primärer Hepatozyten stellt 
zwar eine mögliche Alternative zu Tierversuchen dar, sieht sich allerdings mit 
zwei zentralen Problemen konfrontiert: der begrenzten Verfügbarkeit von 
Lebergewebe sowie der kurzen Lebensdauer dieser Zellen. Daher wurden 
Hepatom-Zelllinien und von hepatozytenähnlichen Zellen aus extrahepatischen 
Zellquellen in Toxizitäts-Assays als mögliche Alternativen untersucht. Jedoch ist 
ihre Verwendung in der Medikamentenprüfung aufgrund ihrer niedrigen 
Expression hepatozytärer Marker und ihrer niedrigen Metabolisierungskapazität 
eingeschränkt. Die Polarisierung spielt eine Schlüsselrolle beim 
Medikamentenstoffwechsel. Deshalb wurde die Hepatotoxizität in 2D und 3D 
(Sandwich)-Kulturen untersucht, wobei Acetaminophen als Modellsubstanz 
verwendet wurde. Unsere Daten zeigten, dass nach der Behandlung mit 
Acetaminophen in 3D-Kulturen mehr Zellen sterben als in 2D-Kulturen, da der 
Metabolismus von Acetaminophen höher ist und sich deshalb eine höhere 
Konzentration von toxischen Metaboliten (NAPQI) bildet. Darüber hinaus wurde 
festgestellt, dass die Proteinexpression von CYP2E1 und SOD1 von der 
Acetaminophen-Konzentration abhängig ist. Daher führte eine Erhöhung der 
Acetaminophen-Konzentration in 3D-Kulturen zu einer gleichzeitigen Erhöhung 
der Expression von CYP2E1 sowie zu einer Verringerung der Expression von 
SOD1, was jedoch in den 2D-Kulturen nicht der Fall war. Darüber hinaus 
wurden für das multidrug resistance-associated protein-1 (MRP1), ein 
spezifisches Transporterprotein für den Transport von Acetaminophen-
Metaboliten, in 3D-Kulturen, höhere Import/Export-Raten festgestellt. 
Schließlich waren die Resultate, die in den 3D-Kulturen erzielt wurden, besser 
mit den Resultaten der in vivo-Situation vergleichbar. 
Allerdings schränken die begrenzte Verfügbarkeit von Lebergewebe sowie die 
Tatsache, dass in kleine Kulturplatten keine Sandwich-Kulturen verwendet 
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werden können, den Einsatz von Sandwich-Kulturen für Hochdurchsatz-
Screenings ein. Daher wurden die primären humanen Hepatozyten in Kollagen-
Gels resuspendiert. Dabei blieben die Zellviabilität, die Glukoseproduktion und 
die NH4-Entgiftung über 28 Tage hinweg in größerem Maße erhalten als in 2D-
Kulturen. Die Messung der metabolischen Phase I- und Phase II-Aktivität zeigte 
ähnliche Ergebnisse. Außerdem verfügten die primären humanen Hepatozyten 
über höhere Import/Export-Raten der beiden Transporterproteine MRP1 und 
multidrug resistance protein-1 (MDR1/P-gp), die sich an der basolateralen 
beziehungsweise der apikalen Membran befinden. Schließlich wiesen primäre 
humane Hepatozyten nach ihrer Stimulation mit Acetaminophen und Diclofenac 
in 3D-Kulturen eine höhere Toxizität auf. 
Die Durchflusskultur primärer humaner Hepatozyten zeigte eine Verbesserung 
der Entgiftungsaktivität. Mikrofluidische Systeme sind jedoch teure Testsysteme, 
deren Einsatz zur Vorhersage von Hepatoxizität nur eingeschränkt möglich ist. 
Daher wurde hier ein einfaches und günstiges mikrofluidisches System getestet. 
Die Daten der Lebend-tot-Färbung zeigten das Überleben der primären 
humanen Hepatozyten im mikrofluidischen System an. Der Stoffwechsel von 
Acetaminophen und Diclofenac, der in statischen Kulturen und in Flusskulturen 
mit der Aktivität von CYP2E1 beziehungsweise von CYP2C9 übereinstimmt, 
führte zu ähnlichen Ergebnissen. Diese Resultate konnten jedoch nicht durch 
Fluroeszenz- oder Absorptionsassays mit Hilfe eines Plattenreaders bestätigt 
werden. Zur Verbesserung der Charakterisierung primärer humaner 
Hepatozyten im µ-Slide-System müssen daher neben alternativen 
Experimenten und der Verbesserung bereits bestehender Methoden neue 
Herangehensweisen entwickelt werden. 
In dieser Arbeit wurde das Verhalten primärer humaner Hepatozyten auf 
natürlichen Kollagen-Gels unter unterschiedlichen Kulturbedingungen 
untersucht. Die extrazelluläre Matrix (EZM) der Leber besteht nicht 
ausschließlich aus Kollagen. sondern enthält außerdem Proteine und 
Proteoglykane. Außerdem sind nicht-parenchymaler Zellen an der 
Entzündungsantwort beteiligt. Daher sollten sich zukünftige Studien auf 
Hepatotoxizitätstests in Ko-Kulturen von primären humanen Hepatozyten und 
nicht-parenchymaler Zellen in mikrofluidischen Systemen mit einer Matrix 
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welche verschiedene Komponenten der Lebermatrix enthält durchgeführt 
werden. Somit könnten in vitro Ergebnisse erzielt werden, die mit der Situation 
in vivo in hohem Maße vergleichbar sind. 
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